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ABSTRACT 
 
SETH MALERI:  Ste7 Variants That Promote Pathway Specific MAPK Signaling In 
Saccharomyces cerevisiae 
(Under the direction of Beverly Errede) 
 
 The yeast S. cerevisiae must respond to a wide variety of external stimuli with the 
appropriate differential program to ensure survival.  Yeast cells transmit signals from 
external environmental cues via signaling cascades to bring about proper transcriptional 
programs.  One such signaling cascade, the Mitogen Activated Protein Kinase (MAPK) 
cascade, is conserved in all organisms.  The MAPK cascade that contains the sequentially 
acting kinases Ste20, Ste11, Ste7 and Kss1 is used in both filamentous growth 
differentiation in response to limiting nutrients as well as differentiation in response to 
mating pheromone.  Despite the shared components signaling fidelity remains. 
 The central kinase in both the mating and filamentous growth differentiation 
pathways is Ste7.  We used a constitutively active version of this kinase to examine if 
biological specificity is lost by removing the need for external stimulus.  We found that 
the constitutively active Ste7 promoted filamentous growth while simultaneously failing 
to support mating differentiation. 
 One version of constitutively active Ste7 that could not be feedback 
phosphorylated in a MAPK dependent manner was unable to bind to the MAPK Fus3 but 
retained the ability to bind to Ste5 and Kss1.  Despite being able to bind to Ste5 this 
version of Ste7 was unable to activate Fus3 but retained the ability to activate Kss1.   
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 The activation of Kss1 by constitutively active Ste7 is independent of the scaffold 
protein Ste5.  Unlike Kss1, Fus3 activation requires Ste5.  We isolated a substitution 
mutation variant of Ste7 that was impaired for binding to Ste5 but not impaired for 
activation of the transcriptional reporter gene for filamentous growth.  This variant of 
Ste7 neither activated Fus3 nor supported mating differentiation in response to 
pheromone.  Yeast cells expressing this variant of Ste7 displayed higher levels of 
phosphorylated Mpk1, the MAPK that functions in response to plasma membrane 
distortions.   
 Our findings uncovered a role for Ste5 in maintaining signal specificity by 
allowing for specific activation of Fus3 by Ste7 in response to mating pheromone.  We 
also uncovered a novel role that Mpk1 may play in the transcriptional response during 
filamentous growth.  These data suggest MAPK signaling occurs through a network 
rather than linear pathways. 
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 CHAPTER 1 
INTRODUCTION 
 
Environmental sensing.  All cells constantly interpret the status of their external 
environment and respond appropriately to changing conditions.  Environmental sensing is 
accomplished most often in eukaryotic cells through a receptor-ligand relationship.  Cells 
contain protein receptors on their surfaces that span the cell membrane and interact with 
specific molecules (ligands) from the environment.  The receptor ligand interaction 
initiates a series of events inside the cell that act on cytoplasmic and nuclear targets 
necessary for the appropriate response. 
 A common receptor-type found in eukaryotic cells is the seven-transmembrane G 
protein coupled receptor (23).  As its name implies these receptors span the cell 
membrane seven times and are coupled to a heterotrimeric G protein inside the cell (23).  
Heterotrimeric G proteins consist of a complex of three protein subunits, α, β, and γ .  
Activation of the receptor allows for exchange of GDP for GTP in the heterotrimeric G 
protein complex on the Gα subunit (39, 40).  This exchange causes the dissociation of the 
Gα subunit from the Gβγ dimmer (39, 40, 109).   Both the Gα subunit and Gβγ dimer can 
serve active roles in cellular signaling pathways once they are dissociated from each 
other (Figure 1.1) (23, 39, 40, 109). 
Another common receptor-type found in most eukaryotic cells is the Tyrosine 
Kinase Receptor (107).  These receptors typically span the membrane once (107).
 2
Tyrosine Kinase Receptors commonly bind to their appropriate ligands as dimmers (1).  
The binding of receptor to ligand then triggers a phosphorylation event on the 
intracellular side of the receptor (1, 107).  Each receptor monomer in the dimer has a 
tyrosine kinase domain that cross-phosphorylates specific tyrosine residues on the 
opposite monomer (1, 107).  This phosphorylation event allows for adapter proteins and 
other effector proteins to associate with the activated receptor and transduce the 
appropriate signal inside the cell (Figure 1.1) (1, 107)  
 The MAP kinase signaling cascade.  Mitogen Activated Protein Kinase 
(MAPK), also known as Extracellular Regulated Kinase (ERK), cascades are found in all 
organisms from yeast to humans (25, 53).  The core of a MAPK cascade has three kinases 
organized into a three tiered module in which each kinase phosphorylates and activates 
the kinase below it (99, 103). Multiple family members for each tier of the MAPK 
cascade are found in every organism (25, 43, 48).  The proteins at each tier can be 
organized into distinct families of kinases.  Once a MAPKKK family member is activated 
it in turn phosphorylates and activates a MAPKK family member by phosphorylation of 
two residues  (serine and a serine or threonine) located in the activation loop of the 
protein (117).  The activated MAPKK family member protein can then phosphorylate and 
activate a MAPK family member  by phosphorylation of a theronine and tyrosine residue 
in the activation loop (Figure 1.2) (13, 38, 43, 48, 54, 55). 
There is a high degree of conservation both in the catalytic domain and catalytic 
mechanism among kinases across each tier of the MAPK module (43, 44).  This 
widespread similarity among protein kinases in the MAPK module requires that there be 
mechanisms in place to ensure signal specificity when a stimulus is encountered.  This 
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specificity is maintained in part by unique levels of regulation at each tier of the MAPK 
cascade.  Typically MAPKKKs possess regulatory domains with motifs that are not 
found in the MAPKKs or MAPKs.  Commonly found motifs include Pleckstrin 
Homology (PH) domains, Src Homology (SH3) domains, leucine zippers, and GTP 
binding domains.  These domains allow for activation of the MAPKKK by specific 
upstream components that respond to a specific stimulus (37, 110).  A second level of 
specificity is maintained at the MAPKK/MAPK level.  The MAPKK proteins possess a 
high degree of specificity for their particular MAPK substrate through high affinity 
protein-protein interaction motiffs.  This specificity allows for minimal cross-talk 
between activated MAPKK and inappropriate MAPKs by creating specific 
MAPKK/MAPK cassettes (2, 3, 26, 37, 54, 64, 74, 75, 110).  Specificity is also 
maintained on a third level by the use of scaffold or anchor proteins.  These scaffold 
proteins ensure that an activated MAPKKK activates the appropriate MAPKK/MAPK 
cassette in response to a certain stimulus.  Examples of well characterized scaffold 
proteins that function in this manner are the Ste5 and Pbs2 proteins in yeast and the 
mammalian JIP family, Mkk4,  KSR and MP1 proteins (17, 30, 37, 47, 96, 115).   
Mammalian MAPK cascades.  A wide variety of external stimuli lead to 
activation of MAPK modules in all eukaryotic cells.  Mammalian cells make wide use of 
MAPK modules in signaling pathways that include responses to cellular differentiation 
factors, cellular growth factors, cellular stress and even viral infections (49, 51, 53, 59, 
94, 100, 104).  The resulting cellular responses include alterations in cellular 
morphology, changes in cell cycle progression, and even the signaling of programmed 
cell death (16, 49, 51, 53, 59, 83, 85, 94, 100, 103, 104).  Based on structural and 
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functional criteria MAPKs can be divided into the Erk (Erk1, 2, 5), Jnk (Jnk1, 2, 3) and 
p38 (p38 α, β, γ) subgroups (Figure 1.3).  Erks predominantly mediate differentiation and 
proliferative responses to growth factors whereas Jnk and p38 family members 
predominantly mediate stress and cytokine induced apoptotic and inflammatory 
responses (reviewed in (83, 104).  
 The extracellular signal-regulated kinases ERK1/2 module is often referred to as 
the classical mitogen kinase cascade.  In this cascade the MAPKs ERK1/2 become 
activated in response to growth factors, serum, and phorbol esters.  The protein that 
activates the MAPK module in this pathway is the proto-oncogene Ras.  A-Raf, B-Raf, 
and Raf-1 function as MAPKKKs in this pathway.  There are two redundant MAPKKs, 
MEK1 and MEK2, and two redundant MAPKs, Erk1 and Erk2.  Active Erk1 and Erk2 
phosphorylate and activate various nuclear and cytoplasmic proteins (Figure 1.3) 
(reviewed in (53, 104).   
The c-Jun N-terminal kinase or stress-activated protein kinases (JNK/SAPK)  
become activated in response to cellular stresses such as UV irradiation and DNA 
damaging agents as well as cytokines such as tumor necrosos factor (TNF)-α (104).  
There are a wide variety of MAPKKKs that function on the JNK protein family 
members.  These include the proteins MEKK1-4, MLK2/3, Tpl-2, DLK, TAO1/2, TAK1, 
and ASK1/2 (104).  The MAPKKs that activate the JNK kinases are MEK4 and MEK7 
(51, 53).  There are three JNK proteins in mammalian cells denoted JNK1-3 (51, 53).  As 
its name implies the transcription factor c-Jun is a target of phosphorylation by the 
MAPK JNK (22, 46).  JNKs have also demonstrated to have other transcription factor 
targets such as ATF-2, NF-ATc1, HSF-1, and STAT3 (Figure 1.3) (37, 51, 53, 83).   
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Similar to the JNKs, the p38 MAPKs are activated in response to cellular stresses 
and cytokines (104).  Examples of cellular stresses are UV irradiation, oxidative stress, 
and hypoxia.  Cytokines such as interleukin-2 and TNF-α also elicit a p38 response 
(104).  The MAPKKKs involved in the activation module for p38 are the same as the 
MAPKKKs involved in activating the JNK modules (104).  The MAPKKs that activate 
p38, MEK3 and MEK6, are highly specific for p38 as they do not activate ERK1/2 or 
JNK (Figure 1.3) (37, 53, 104).   
MAPK Modules in Yeast.  There are no less than five signaling pathways in 
yeast that utilize a MAPK module to elicit an appropriate response to altered 
environmental conditions.  Three of these share common components but nevertheless 
have exquisite specificity with respect to alterations in physiology elicited by a specific 
stimulus. 
Spore wall biogenesis.  Diploid yeast undergo meiotic cell division in response to 
low nutrient conditions to produce 4 haploid spores.  Two proteins involved specifically 
in the sporulation process are the MAPK homolog Smk1 and the MAPKKKK homolog 
Sps1 (33, 57).  When faced with the proper stimuli for sporulation yeast lacking these 
proteins undergo meiosis properly and form four haploid nuclei but are defective in 
forming proper spore cell walls (33, 57).  A second phenotype observed in cells lacking 
these kinases is an altered expression of late sporulation genes (81).  Unlike the other four 
signaling pathways in yeast that utilize MAPK modules, there has yet to be a well defined 
MAPKKK and MAPKK involved in the sporulation process (Figure 1.4) (25, 33, 57, 81).                               
High osmolarity response.  The high osmolarity glycerol (HOG) response 
signaling pathway also utilizes a MAPK module.  Yeast respond to the stimulus of high 
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external osmolarity by increasing internal concentrations of glycerol to maintain proper 
turgor pressure.  The components of the MAPK module involved in this signaling 
pathway are well defined.  The Sho1 membrane protein and the two component kinase,  
Sln1/Ssk1, activate two branches of the pathway that converge to activate the MAPKK 
Pbs2.  The Sho1 branch utilizes the MAPKKK Ste11 to activate Pbs2 while the 
Sln1/Ssk1 branch utilizes Ssk2/Ssk22 to activate Pbs2 (78, 86, 95, 96).  Pbs2 in turn 
phosphorylates and activates the MAPK Hog1 (9, 11).  Pbs2 not only serves as the 
MAPKK in this cascade but also serves as a protein scaffold as it binds to Sho1, Ste11 
and Hog1 (96).  Cells lacking the MAPK Hog1 exhibit sensitivity to high external 
osmolarity such as 1M NaCl or 1.5M sorbitol after 5-20 generations (11).  Another 
phenotype of a Hog1 deficiency is the loss of negative regulation that normally inhibits 
basal signaling in the mating pathway (Figure 1.4) (84). 
Cell wall integrity.  The cell wall integrity signaling pathway is utilized when 
yeast cells experience membrane distortions and the cell wall must coordinate growth to 
maintain proper cell integrity.  Examples of stimuli that activate this pathway include 
heat shock, reduced external osmolarity, mating pheromone and polarized growth 
(reviewed in(28).  Components of this pathway are Pkc1, the MAPKKK Bck1, two 
redundant MAPKKs, Mkk1 and Mkk2 and the MAPK Mpk1 (also called Slt2) (52, 62, 
63, 67, 90, 112).  When cells are deficient for the MAPK Mpk1 they experience cell lysis 
when grown at 37°C (Figure 1.4) (28, 52, 62, 63, 112).   
Filamentous growth response.  Filamentous growth is a differentiation program 
that occurs in both haploid and diploid cells.  In haploid cells the differentiation process 
is termed invasive growth while in diploids the differentiation process is called 
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pseudohyphal growth.  The signal for invasive growth differentiation in haploids is low 
glucose while low nitrogen triggers differentiation in diploids (21, 41).  Both processes 
require growth on solid media.  The filamentous growth response results in cells with 
elongated morphology, the physical attachment of mother and daughter cell walls after 
budding, and the ability to invade solid medium (41).  Various sensors have been 
implicated in sensing the proper nutrient limitations to induce filamentous growth.  The 
glucose sensor, Gpr1, the glucose transporters Rgt2 and Snf3, the nitrogen permeases 
Mep1/2/3, and the previously mentioned osmolarity sensor Sho1 in conjunction with the 
Msb2 protein are all utilized in activating this response (Figure 1.4) (35, 71, 72, 87, 88).   
Filamentous growth in both haploids and diploids is comprised of two distinct 
signaling branches.  One branch is a cAMP/PKA pathway while the other is a MAPK 
pathway (34).  The MAPK module is comprised of the MAPKKKK Ste20, the 
MAPKKK Ste11, the MAPKK Ste7, and the MAPK Kss1 (69).  The specific role of the 
MAPK Kss1 in this response pathway and in the mating differentiation pathway (below) 
is discussed in detail in the next section. 
Mating differentiation pathway.  Haploid yeast make use of the mating 
differentiation pathway in order to form a diploid cell.  When haploid yeast encounter the 
appropriate mating pheromone from the opposite mating type cell they initiate a signaling 
process that results in arrest at the G1 stage of the cell cycle, the formation of a mating 
projection, and the transcription of genes necessary for mating events such as cell fusion.  
Efficient mating projection formation relies on the G1 arrest event.  The mating 
projection (referred to as a schmoo) then serves as the point of contact for fusion between 
two mating cells (Figure 1.4).   
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The mating differentiation pathway uses the same kinases as the filamentous 
growth pathway (69).  In particular to the mating differentiation pathway however a 
second MAPK, Fus3, is utilized as well as a scaffold protein, Ste5 (reviewed in (25, 28).  
Both MAPKs have a partial redundancy in this pathway but as is discussed in detail in the 
next section, Fus3 has a predominant role compared to Kss1 (77).     
It is clear that MAPK modules play crucial roles in a wide array of signaling 
pathway from mammals to yeast.  In my studies I have chosen to focus on two distinct 
signaling pathways in yeast that involve MAPK modules, the mating pheromone 
response pathway and the filamentous growth pathway.  These two signaling pathways 
present an interesting challenge because they share many of the same proteins yet 
maintain signal specificity.  For example, exposure of yeast to physiological levels of 
mating pheromone does not promote filamentous growth.  In a similar fashion, haploid 
cells growing under conditions of low glucose do not elaborate mating projections.  The 
similarities and differences between these two pathways are outlined below.    
       Yeast Mating Pheromone Response Pathway.  Preparation for mating is 
initiated when haploid yeast of opposite mating types (a or α) are exposed to a peptide 
pheromone secreted by the opposite mating partner.  Mating type a cells produce a-factor 
while mating type α cells produce α-factor.  The pheromone receptor, Ste2, on a-type 
cells binds to the secreted peptide pheromone α-factor while the Ste3 receptor on α-type 
cells binds to secreted a-factor (6, 8, 23).  This binding event triggers the exchange of 
GDP for GTP on the heterotrimeric G-protein associated with the pheromone receptor.  
The exchange of GTP for GDP causes the dissociation of the Gα subunit (Gpa1) from the 
Gβγ (Ste4, Ste18 respectively) in the heterotrimeric G protein (6, 8, 23).  The free Gβγ 
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dimer plays an important role in recruiting the necessary components to activate the 
MAPK cascade to the plasma membrane at a site that will eventually become the tip of 
the mating projection.   
Free Gβγ  makes three key interactions upon pheromone stimulation.  One 
interaction is between free Gβγ and the Far1 protein associated with its Cdc24 cargo (12, 
82).  The Cdc24 protein is a guanine nucleotide exchange factor (GEF) for the G-protein 
Cdc42 (118).  The Cdc42 protein interacts with the Cdc24, free Gβγ dimer, Far1 and 
Bem1 (12, 65, 73, 91, 93).  A second interaction that takes place at the activated 
pheromone receptor is between activated Ste20 and free Gβγ.  This interaction is mediated 
specifically between the Gβ (Ste4) subunit of the Gβγ dimer (66).  Ste20 also localizes to 
mating projection tips through its association with Cdc42 as mentioned above.  Finally 
the free Gβγ  interacts with the MAPK cascade scaffold protein Ste5 (Figure 1.5) (31, 50, 
116).  The Ste5 scaffold protein associates with the MAPK module proteins Ste11, Ste7 
and Fus3 (17, 98).  The release of free Gβγ  upon mating pheromone stimulation therefore 
serves to assemble the necessary components of the MAPK signaling module in close 
proximity to what will become the mating projection tip (Figure 1.5) (23).    
The scaffold protein Ste5 plays an integral role in organizing the MAPK module 
of the mating pathway.    It has been shown that Ste5 associates with all the components 
of the MAPK cascade (Ste11, Ste7, and Fus3) by two-hybrid, glycerol gradient 
sedimentation and GST pull down experiments (17, 98).  The MAPK Kss1 associates 
with the module via its interaction with Ste7 (10).  Organization of the MAPK module is 
not the sole function of Ste5.  Ste5 translocates from the nucleus to the cell membrane 
when the pheromone receptor is engaged with its appropriate ligand (79, 97, 108).  This 
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translocation event poises Ste5 associated Ste11 to interact with activated Ste20, which 
phosphorylates and activates Ste11 (32, 108).  Ste5 also positions Ste11 to interact with 
Ste7.  This positioning facilitates Ste11 to phosphorylate and activate Ste7.  Association 
of Ste5 with both Ste7 and the MAPK Fus3 has a cooperative effect on enhancing the 
efficiency of signal transduction in the mating pathway (7, 45, 80, 108).   
The MAPK Fus3 is the primary MAPK that functions in the pheromone response 
pathway (74, 77).  Both Fus3 and Kss1 are activated to an equivalent extent in response 
to mating pheromone but Fus3 has specific substrates that Kss1 does not (10, 29, 106).  
The cell cycle regulator protein Far1 is the primary example of a specific Fus3 target.  
Phosphorylation of Far1 by Fus3 leads to the G1 arrest of cells.  This arrest is a 
prerequisite for the morphogenesis leading to the formation of a mating projection 
(Figure 1.5) (14, 15, 92, 113).   
To initiate the mating specific transcriptional response in yeast the transcription 
factor a repressor complex must be removed from the transcription factor Ste12.  This 
repressor complex consists of two redundant proteins Rst1 and Rst2 (also called Dig1 and 
Dig2 respectively).  The current model of how this repression is removed is that activated 
MAPK (Fus3 or Kss1) phosphorylate the transcription repressor proteins Rst1 and Rst2 
(Figure 1.5) (111).  This event causes them to dissociate from Ste12 and allows for 
transcription of mating specific genes (MSGs).  Ste12 is found to be poised as homo-
multimers at pheromone response elements (PREs) or as heterodimers with the Mcm1 
protein at P-box elements in close proximity to PREs at promoters for MSGs (24, 27) 
 Filamentous Growth.  The transition to filamentous growth in haploid and 
diploid cells is mediated by two branches that comprise a signaling network.  One branch 
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involves the activation of Gpa2 and Ras2 which ultimately leads to activation of protein 
kinase A (PKA) (reviewed in (34, 36, 89).  The other branch is mediated by a PAK 
activated MAPK module (see (34, 36, 89).  I will choose to focus on the MAPK mediated 
branch as it pertains to filamentous growth in haploid yeast.  I will refer to haploid 
filamentous growth as invasive growth to distinguish it from diploid pseudohyphal 
growth. 
 Haploid invasive growth occurs on rich media when glucose becomes limited and 
there is some evidence that certain alcohols (i.e. isoamyl alcohol or butanol) can also 
induce the transition (21, 70, 89).  The Sho1 protein associated with Msb2 has been 
implicated as the sensor necessary for activation of the MAPK branch of the signaling 
network for invasive growth (20).  Sho1 is one of the sensors involved in sensing high 
osmolarity conditions that result in activation of the HOG pathway (78).  It is the specific 
interaction between Sho1 and Msb2 that poise it to function in the invasive growth 
pathway (Figure 1.6) (20).   
Under conditions of low glucose the Sho1/Msb2 receptor combination recruits 
and activates the Cdc42 protein at the plasma membrane (20).  It has been demonstrated 
that the invasive growth signaling pathway requires Msb2 to function (20).  There is no 
evidence that the Msb2 protein interacts with the known GEF for Cdc42, namely Cdc24 
(20).  It is surmised that the Msb2 protein activates the Cdc42 protein directly.  Activated 
Cdc42 can then in turn activate the PAK/MAPKKKK protein Ste20 (Figure 1.6) (20). 
 The MAPK dependent branch of filamentous growth involves many of the same 
proteins involved in the mating pheromone response pathway.  Including the 
PAK/MAPKKKK protein Ste20, the MAPKKK module Ste11, the MAPKK Ste7, and 
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the MAPK Kss1 (34, 36, 68, 69, 89).  As observed in the mating differentiation pathway, 
activated Kss1 phosphorylates the repressor complex consisting of Rst1 and the 
transcription factors Ste12 and Tec1 to allow for transcription of genes involved in 
invasive growth (4, 18, 19, 74, 77, 111) .     
Despite the similarities between the MAPK module of the filamentous growth 
pathway and the MAPK module of the mating pheromone response pathway there are 
differences that help contribute to signal specificity.  The most noteworthy difference is 
the lack of a well defined scaffold protein for the filamentous growth pathway.  A second 
difference is the dispensability of the Fus3 MAPK in the filamentous growth pathway.  
Indeed haploid yeast penetrate agar more efficiently in a Fus3 deficient strain suggesting 
an inhibitory role for Fus3 in the invasive growth response (77).  Conversely haploid 
strains deficient in Kss1 show a reduction in their ability to penetrate agar suggesting an 
activating role for Kss1 in the pathway (4, 77).  Finally there is a difference in promoter 
elements for genes expressed in response to pheromone versus filamentous growth 
response.  Specific promoter elements direct Tec1-Ste12 heteromultimers to filamentous 
growth response genes while other promoter elements direct Ste12-Ste12 homomultimers 
to pheromone response genes (Figure 1.6) (5, 24, 27, 74). 
Ste12 and Tec1 transcription factor complexes.  Ste12 is a transcription factor 
initially identified for its role in the regulation of genes involved in the mating 
differentiation developmental pathway (24, 27).  The Ste12 protein contains a DNA 
binding domain that associates with the consensus sequence TGAAACA in DNA at 
promoters (Figure 1.7) (27).  This consensus sequence has been termed a pheromone 
response element (PRE) because of its prevalence in promoters of genes expressed in 
 13
response to mating pheromone (24, 27, 58, 114).  Very often there are multiple PREs in 
the promoters of genes involved in the mating response as Ste12 forms homodimers and 
binds poorly to a single PRE (42).  The multiple PREs allow for cooperative binding of 
Ste12 homodimers which allows for transcription (24, 27, 42).  Examples of genes that 
contain PREs and are expressed in response to mating pheromone are the SST2, FUS1, 
and FUS2 (42, 101, 102).  In particular the FUS1 promoter fused to various reporter 
genes the standard promoter used to identify activation of the MAPK module involved in 
the mating differentiation pathway (Figure 1.7) (42).  The FUS1 promoter contains four 
copies of the PRE in its promoter (42).  These elements are responsible for the 
stimulation of the Ste12-Ste12 driven expression of the FUS1 gene in response to 
pheromone (42). 
 Tec1 is a transcription factor initially discovered for its role in regulating 
Ty1 retrotransposon gene expression (60).  The Tec1 protein binds to DNA at the 
consensus sequences CATTCC/T (Figure 1.7) (74).  These sequences have been termed 
TEA (TEF-1, Tec1, AbaAp)/ATTS (AbaAp, TEF-1, Tec1, Scalloped) sequences because 
the transcription factors that bind to these sequences have an evolutionary conserved 
DNA binding domain (61, 74).  In yeast these sequences are often referred to as Tec1 
consensus sites (TCS).  Many promoter regions of genes involved in filamentous growth, 
including haploid invasive growth, contain TCS elements in close proximity to 
previously mentioned PREs.  This combination of elements serves to enhance gene 
transcription and has been termed a filamentation and invasion response element (FRE) 
(61, 74).  Both transcription factors Ste12 and Tec1 bind to FREs in a cooperative 
manner as heteromultimers (5).  Examples of gene that contain FREs are the cell surface 
 14
flocculin FLO11 and the TEC1 promoter itself (74, 105).  Not all genes involved in 
invasive growth contain FREs however.  For example the PGU1 promoter contains 
several isolated TCS elements without proximal PREs necessary to form a FRE (56, 76).  
Tec1 was originally discovered for its role in Ty1 transcription regulation so therefore a 
synthetic FRE based upon sequences in the Ty1 promoter is often used to measure Tec1 
activation by the MAPK branch of filamentous growth (5, 60, 74).  This promoter 
contains both TCS and Ste12 binding sites to form a canonical FRE (Figure 1.7) (5, 74).      
In my thesis I have chosen to focus on the MAPKK protein Ste7.  I chose to study 
this protein because of its central role in both MAPK cascades that are involved in the 
haploid differentiation processes of mating and invasive growth.  I have examined how 
activation by Ste11 and feedback phosphorylation by Fus3 and Kss1 affect how Ste7 
interacts with its other members of the MAPK module.  I have also examined the effects 
of constitutive activation of Ste7 has on its ability to function in the mating pheromone 
response pathway versus the filamentous growth developmental program.  Finally I have 
identified a residue essential for the interaction between Ste7 and the scaffold protein 
Ste5 and examined how these interactions influence the ability of Ste7 to function in the 
mating pathway versus the filamentous growth pathway.  The results of my experiments 
will be shown in the following chapters. 
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Figure 1.1:  Two common receptor types.  Receptor tyrosine kinases commonly span the 
plasma membrane once and bind to ligands as dimmers.  When bound to ligands the 
intracellular tyrosine kinase domains cross-phosphorylate each other leading to an 
activated receptor.  Once activated the receptor can activate numerous downstream 
effectors which can in turn act on downstream targets.  G-protein coupled receptors 
typically span the plasma membrane seven times and are coupled to a heterotrimeric G-
protein on the intracellular side of the membrane.  The heterotrimeric G protein consists 
of α, β, and γ subunits.  When a G-protein coupled receptor is activated by its cognate 
ligand it promotes the exchange of GTP for GDP on the Gα subunit which causes its 
dissociation from the Gβγ subunits.  Once dissociated, both the Gα subunit and Gβγ 
subunits can activate downstream effectors which can in turn also activate other 
downstream targets. 
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Figure 1.2:  The MAPK cascade.  Each tier of the cascade activates the tier below it by 
phosphorylating residues in the “activation loop.” 
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Figure 1.3:  Examples of MAPK modules in mammalian cells. 
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Figure 1.4:  Yeast MAPK modules. 
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Figure 1.5:  The yeast mating differentiation signaling pathway and morphology.  See 
text also for explanation.  Mating pheromone activates a G-protein coupled receptor 
causing dissociation of the Gα subunit from the Gβγ subunits.  The Gβγ subunits then 
recruit many protein complexes to the plasma membrane including the scaffold protein 
Ste5.  Ste5 is associated with Ste20 which initiates activation of the MAPK cascade 
consisting of Ste11 (MAPKKK), Ste7 (MAPKK), Kss1 (MAPK), and Fus3 (MAPK).  
Both Fus3 and Kss1 activate Rst1 and Rst2 which allows for transcription of mating 
specific genes by Ste12.  Fus3 has other targets, such as Far1, that Kss1 does not.  
Activation of Far 1 leads to arrest in the G1 stage of the cell cycle.  This arrest is 
prerequisite for the morphological change to a mating competent form (schmoo).    
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Figure1.6:  Filamentous growth differentiation signaling pathway and morphology.  
Yeast use the Sho1 osmosensor in conjunction with the Msb2 protein to detect low 
nutrient levels.  Detection of low nutrient levels leads to activation of Ste20 which 
activates the MAPK cascade consisting of Ste11 (MAPKKK), Ste7 (MAPKK), and Kss1 
(MAPK).  Kss1 activates Rst1 which allows for transcription of filamentous growth 
specific genes by Ste12 in conjunction with Tec1.  The morphological changes that result 
are cell elongation, unipolar budding, and mother daughter attachment at the bud site 
neck after cell division. 
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Figure 1.7:  Definition of Pheromone responsive element (PRE) and Filamentous growth 
responsive element (FRE). 
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CHAPTER 2 
PERSISTENT ACTIVATION BY CONSTITUTIVE STE7 PROMOTES KSS1-
MEDIATED INVASIVE GROWTH BUT FAILS TO SUPPORT FUS3-DEPENDENT 
MATING IN YEAST 
 
Abstract 
The MAPKKK-Ste11, MAPKK-Ste7, and MAPK-Kss1 mediate pheromone-
induced mating differentiation and nutrient responsive invasive growth in S. cerevisiae.  
The mating pathway also requires the scaffold-Ste5 and the additional MAPK-Fus3.  One 
contribution to specificity in this system is thought to come from stimulus-dependent 
recruitment of the MAPK cascade to upstream activators that are unique to one or the 
other pathway.   To test this premise, we asked if stimulus-independent signaling by 
constitutive Ste7 would lead to a loss of biological specificity.  Instead, we find that 
constitutive Ste7 promotes invasion without supporting mating responses.  This 
specificity occurs because constitutive Ste7 activates Kss1, but not Fus3, in vivo and 
promotes filamentation gene expression while suppressing mating gene expression.  
Differences in the ability of constitutive Ste7 variants to bind the MAPKs and Ste5 
account for the selective activation of Kss1.  These findings support the model that Fus3 
activation in vivo requires binding to both Ste7 and the scaffold-Ste5 but that Kss1 
activation is independent of Ste5.   This scaffold-independent activation of Kss1 by 
constitutive Ste7 and the existence of mechanisms for pathway-specific promoter 
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discrimination impose a unique developmental fate independently of any 
distinguishing external stimuli.    
 
Introduction 
In response to the appropriate environmental stimulus haploid cells of S. 
cerevisiae are capable of two developmental fates.  One entails differentiation into a 
mating competent form and the other is a switch from vegetative to pseudohyphal 
growth.  Mitogen activated protein kinase (MAPK) pathways comprised of the same 
enzymes mediate both transitions.  This situation offers an excellent opportunity for 
studies into regulatory mechanisms that impart biological specificity to signaling 
pathways.    
Mating is the fusion of two haploid cells of opposite mating types to produce a 
diploid cell.  Differentiation to a mating competent form is triggered when pheromone 
from the opposite mating type binds to a G-protein coupled receptor.  The activated G-
protein stimulates a MAPK module comprised of the p21 (Cdc42) associated kinase 
(PAK)-Ste20, the MAPKKK-Ste11, the MAPKK-Ste7 and two MAPKs, Fus3 and Kss1 
(Figure 2.1, see (36) for review).  The scaffold-Ste5 organizes the core enzymes of this 
pathway by directly binding to Ste11, Ste7 and Fus3 (36).  Kss1 does not bind directly to 
Ste5 but is part of this complex through binding to Ste7 (17).   Although Fus3 and Kss1 
kinase activity is induced to an equivalent extent in pheromone-treated cells, Fus3, but 
not Kss1, has specificity for critical substrates, such as Far1, that are dedicated to the 
mating differentiation response (17, 54, 156).  Fus3 and Kss1 are equivalent with respect 
to promoting a mating-specific transcription program through their activation of the 
Ste12 transcription factor (17, 149, 181).  MAPK activation of Ste12 involves 
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phosphorylation-dependent inactivation of two inhibitors called Rst1 (Dig1) and Rst2 
(Dig2) (170).  Ste12 functions at mating specific genes (MSG) either as a homo-multimer 
at promoters with reiterated pheromone response elements (PREs) or in conjunction with 
Mcm1 at promoters with P-box elements in proximity to PREs (38, 47)(Figure 2.1).    
The transition from vegetative to pseudohyphal growth is induced in diploid cells 
on solid medium containing a good carbon source but limiting in nitrogen (75).  A related 
transition causing haploid cells to invade solid medium occurs on rich medium in 
response to glucose depletion or high alcohol (see (136) for review).  In the pseudohyphal 
and invasive growth mode, chains of elongated cells remain attached at the mother-
daughter neck to form the pseudohyphal filaments that emanate from the periphery of 
colonies (136).  Regulation of the transition to filamentous growth involves a network of 
several signaling pathways (Figure 2.1).  The glucose sensing G-protein coupled 
receptor-Gpr1 stimulates one branch of the network through Gα-Gpa2, which together 
with Ras2 regulates cAMP production and protein kinase A (PKA) activity (136).  The 
Sho1 and Msb2 transmembrane proteins are upstream regulators of the MAPK-mediated 
branch of the network (35, 131) (P. Cullen and G. F. Sprague, Jr., personal 
communication).  With the exception of Fus3, the same kinases used in the mating 
pathway comprise the filamentous growth MAPK activation module (Figure 2.1) (136).  
Another notable difference is that there is no known scaffold for the invasive pathway.    
The Kss1 branch of the pseudohyphal signaling network regulates the filamentation-
specific transcription program through activation of the Ste12 transcription factor by 
phosphorylation-dependent inactivation of the Rst1 (Dig1) and Rst2 (Dig2) inhibitors (9, 
31, 170).  Ste12 acts at filamentation specific genes (FSG) co-operatively with Tec1 at 
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promoters that have a Tec1 consensus binding sequence (TCS) in proximity to the PRE 
binding element for Ste12 (12, 113)(Figure 2.1). 
Thus, the transcriptional output for the mating and invasive response depends on 
the same transcription factor and inhibitor complex, which can be activated by either 
Kss1 or Fus3.  How and whether transcriptional specificity occurs in this circumstance is 
still poorly understood.  Recent evidence from genome-wide location analyses suggests 
that regulation of Ste12 binding at the different promoters rather than selective activation 
by the two MAPKs regulates the distinct gene expression programs associated with 
mating differentiation and filamentous growth (181).  
While filamentous growth is persistent, mating differentiation is transient.  The 
transient signal results because cells reenter the cell cycle to resume vegetative growth 
whether or not mating occurs.  Accordingly, the responsiveness of cells to persistent 
pheromone induction diminishes with time.  This phenomenon occurs through several 
desensitization or adaptation mechanisms that impinge on different components of the 
signaling pathway upstream of the MAPK activation module (see (36) for review).  Rapid 
attenuation of MAPK activation is reinforced through pheromone-dependent mechanisms 
that directly affect the MAPK module enzymes themselves.  Examples include 
dephosphorylation of the MAPKs by phosphatases, one of which is induced by 
pheromone, ubiquitin-dependent turnover of Ste11 that apparently depletes activated 
Ste11 from the Ste5-organized complex, and ubiquitination of Ste7 upon prolonged 
pheromone exposure (26, 37, 51, 66, 71, 173).   
Pheromone-induction also regulates the phosphorylation status of Ste7.  Similar to 
other MAPKKs, Ste7 activation requires phosphorylation of two residues in the 
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activation loop (49, 128, 183).  In addition, both Fus3 and Kss1 mediate 
hyperphosphorylation of Ste7 in a feedback reaction that is contemporaneous with their 
activation (48, 49, 186, 187).  We subsequently showed that Fus3 directly phosphorylates 
multiple residues in the Ste7 N-terminal regulatory domain and a single residue C-
terminal to the catalytic domain (Ref (49) and supplementary data to this paper.)   
Because Ste7 is also a direct substrate for Kss1, it is likely that both MAPKs target the 
same subset of residues (8). 
Little is known about how feedback phosphorylation of Ste7 affects its activity and 
subsequent MAPK activation.  Early observations indicated that the hyperphosphorylated 
Ste7 is less represented than the hypophosphorylated form in the Ste5-scaffold complex 
(27).   Additionally, Ste7 in vitro kinase activity is significantly lower when the enzyme 
is isolated from cells expressing Fus3 and Kss1 than from cells lacking both MAPKs (48, 
49).  These observations suggest that feedback phosphorylation contributes to attenuation 
of signaling in the mating differentiation pathway.  It has not been resolved whether the 
decrease in pheromone stimulated Ste7 activity occurs because the hyperphosphorylated 
form has attenuated specific activity, is excluded from the interactions with components 
of the MAPK- module, or is targeted for ubiquitination.  
In this study we employed Ste7 activation loop and feedback phosphorylation site 
substitution variants to examine the above questions.  We show that feedback 
phosphorylation of Ste7 does not attenuate its kinase activity nor influence its 
susceptibility to pheromone induced ubiquitination. Unexpectedly, we find that 
constitutive Ste7 specifies an invasive response through selective activation of Kss1 and 
filamentation-specific gene expressions.  The selective transcriptional output occurs 
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because mating-specific gene expression is suppressed through mechanisms that are 
dependent on the feedback phosphorylation status of Ste7. 
Materials and Methods 
Yeast genetic procedures and strains.  Unless otherwise specified, yeast growth 
media and genetic manipulations were employed as described by Sherman et al. (162).  
Yeast transformations and gene replacements were done using standard procedures (73, 
153).  All gene replacements or integrations were confirmed by polymerase chain 
reaction analysis of genomic DNA.  Table 2.1 lists the strains used in these studies and 
their complete genotype.  The details of how they were constructed are provided in an on-
line supplement to this paper. 
Recombinant DNA procedures and plasmids.  Bacterial transformations, 
bacterial DNA preparations, plasmid constructions and DNA restriction enzyme 
digestions were performed by standard methods (157).  A list of the plasmids used in 
these studies is provided in Table 2.2.  The details of site-directed mutagensis for 
generating alanine or glutamate substitutions at the phosphorylation sites of Ste7 and for 
different plasmid constructions are provided in supplemental methods. 
Mating response and pheromone induction assays.  Mating competence was 
scored by an assay for prototrophic diploid formation between MATa strain C699-89 
(ste7∆4::HisG) expressing STE7 alleles from plasmids as specified, and MATα tester 
strain KZ8-1D (80).  As a control to confirm mating dependence of prototroph formation, 
parallel mating mixtures were made using MATa tester strain KZ8-5C.  Semi 
quantitative comparisons were made as follows.  Mid-log phase cultures of tester strains 
were used to make grids with 106 cells per spot on complete medium (YPD).   Strains to 
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be tested were grown to mid log phase in selective medium (-Ura).  Ten-fold dilutions 
were made and used for applying 105, 104, 103 and 102 cells from each culture to a tester 
strain spot on a grid on the solid medium.  Mixtures were incubated at 30oC and then 
replica plated onto medium for selection of prototrophic diploids (SD).  Growth was 
scored after overnight incubation at 30oC.  
FUS1-lacZ expression is a standard reference for pheromone-induced and mating 
pathway specific transcription (80).  Reporter gene expression was measured by activity 
of the lacZ gene product (β-galactosidase) in whole cell extracts as previously described 
(147).  Pheromone induced G1 arrest was monitored by the percentage of unbudded cells 
in the sample using a microscope and a hemacytometer grid to count cells.  Pheromone 
induced mating differentiation was monitored by the percentage of cells with mating 
projections using the same procedure.  At least 200 individual cells were scored for each 
sample.        
Invasive growth and filamentation reporter gene assays.  Growth chambers for 
visualizing invasive growth were made from two 3 x 1 inch glass microscope slides 
separated by a 5 mm wide and 1.5 mm thick U-shaped spacer.  The spacer and slides 
were held in place using a ¾” wide binder clip at each end of the assembly.  The chamber 
assemblies were autoclaved without media in glass petri dishes.  Immediately before use, 
sterilized YPD medium with 1.5% agar was liquefied by microwave heating and 
delivered into each sterilized assembly using a syringe with an 18-guage needle.  Cultures 
of strains to be tested were grown to mid-log phase in selective medium.  25 µl of a 1 x 
104 cell/ml dilution was applied to the solid medium in the trough between the 
microscope slides.  After inoculation, the chambers were wrapped in saran, placed 
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vertically in plastic boxes containing wet 3mm paper to maintain humidity and incubated 
at 30oC.  After ~48 hr, images of colonies that grew beneath the agar surface were 
visualized using an Axioplan Research Microscope with a 2.5 X objective. Images were 
captured using an Axio Cam camera with Zeiss Axiovision software.  Images were taken 
at ~4 mm intervals allowing a sampling of 8-10 separate fields from each growth 
chamber.  The area of individual colonies from images at each interval was measured 
using NIH ImageJ software. 
Ty-lacZ expression is a standard reference for filamentation pathway specific 
transcription (113, 117, 126).  The pNC343 plasmid version of this reporter that we 
employ has the composite Tec1 Ste12 binding element from Ty1 replacing the upstream 
activating sequence (UAS) of the CYC1 promoter in pLG∆178   (12, 78).  This context 
differs from TDH3 context of the FG-TyA-LacZ (pIL30) reporter that has been more 
generally used (99, 126).  In our hands the FG-TyA-LacZ reporter has high basal 
expression compared with the pNC343 reporter plasmid.  Additionally the pNC343 Ty-
LacZ reporter shows a more stringent dependence on components of the MAPK cascade, 
including Ste7 and Kss1.  Reporter gene expression was measured by activity of the lacZ 
gene product (β-galactosidase) in whole cell extracts as previously described (147).    
Immune precipitation kinase assays.   In vitro assays of Ste7 catalytic activity 
were performed directly on immune complexes of myc-epitope tagged Ste7 (Ste7M) with 
γ−32P−ATP and catalytically inactive Fus3R42 as substrate.  The source of Ste7M or 
variant proteins was from strain K2149 (bar1∆ FUS3 KSS1) or K2313 (bar1∆ fus3∆ 
kss1∆) transformed with plasmids expressing Ste7M (or variants) from the CYC1 
promoter.  Strains were grown in selective medium (-Trp) to a density of ~1 x 107 
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cells/ml.  Samples were removed before and after 30 min of induction with mating 
pheromone (α-factor, 50 nM).  Native protein extracts were prepared from samples as 
previously described (48).  Fus3R42 substrate polypeptide was prepared as a GST fusion 
protein produced in E. coli.  The fusion protein was isolated on glutathione-agarose 
columns, eluted and treated with thrombin to release the GST polypeptide as described 
elsewhere (167).  The resulting mixture was used as substrate without further 
purification.   
Immune complexes were isolated using buffers and wash conditions as previously 
described (48).  For each assay we used 400 µg of extract with 22 µg anti-myc 9E10 
antibodies (53), and 50 µl protein A sepharose beads (Pharmacia-LKB).   These specific 
conditions were empirically determined to be in the linear range for activity vs. immune 
complex (beads).   Immune complex beads were suspended in 6 µl of kinase assay buffer 
(25 mM HEPES [N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid, pH 7.2], 15 mM 
MgCl2, 5 mM EGTA, 1 mM dithiothreitol, 0.1 mM orthovanadate, 15 mM 4-
nitrophenylphosphate, 1 mM PMSF, 2 µg leupeptin per ml, 40 µg of aproptinin per ml.)  
Approximately 250 ng of thrombin treated GST-Fus3R42 substrate in a volume of 2-5 µl 
was added to the above suspension.  The reactions were initiated by addition of an ATP 
mix (1 µl of 250 mM HEPES, pH 7.2, 2 µl 1 mM ATP, 0.2 µl of [γ-32P]ATP [Dupont-
NEN, 10 µCi/µl],  2.4 µl of 100 mM MgCl2) and water to give a final reaction volume of 
20 µl.  The mixtures were incubated at 30oC for 20 min and reactions were terminated by 
addition of an equal volume of 2 X SDS PAGE buffer and boiling for 3 min.  Proteins in 
the reaction were fractionated by sodium dodecylsulfate-polyacrylamide gel 
electrophoresis (SDS-PAGE) (7.5%).  The portion of the gels that includes the immune 
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precipitated Ste7 (above the 45 kD molecular size-marker) was transferred to 
nitrocellulose membranes for detection of the amount of Ste7M in the IP-complex using 
anti-myc antibodies.   The lower portion of the gels that includes Fus3-R42 and 
immunoglobuin chains, was dried to determine the amount of 32P incorporated into Fus3-
R42 by PhosphorImage analysis (Molecular Dynamics). 
GST fusion protein co-purification assays.   Either strain C699-92 (ste5∆ 
ste11∆ ste7∆ fus3∆ kss1∆) or C699-93 (ste11∆ fus3∆) was co-transformed with a plasmid 
for GAL1,10 promoter expression of one of the Ste7M phosphorylation site variant 
proteins (pNC809, pNC896, pNC897, pNC898, or pNC906) and GST (pEG-KT) or GST-
fusion proteins (pNC901, pNC903, pRD-GST-STE11 or pYBS293).  Cultures of each co-
transformed strain were grown in selective medium (-Trp - Ura3) with raffinose (2%) as 
the carbon source.  When cultures reached a density of  ~1 x 107 cells/ml, galactose (2%) 
was added to the medium to induce expression of the Ste7M variant and the GST-fusion 
protein.   After 6 hrs of induction, cultures were harvested and cell pellets were 
suspended in an equal volume of modified H-buffer (25 mM Tris pH 7.4, 15 mM 
ethylene glycol tetra acetic acid [EGTA], 15 mM MgCl2, 1 mM dithiothrietol, 1 mM 
sodium azide, 0.1% Triton X-100) made with 10% glycerol and containing phosphatase 
and protease inhibitors (0.25 mM orthovanadate, 1 mM  phenylmethylsulfonyl fluoride 
[PMSF], 5 µg/ml each pepstatin A, chymostatin, anti-pain and aprotinin).   Cells in the 
suspensions were broken by vigorous shaking with an equal volume of glass beads on an 
IKA platform mixer at 4oC for a total of 12 min.  Glass beads and cellular debris were 
removed by centrifugation at 4oC and the supernatant was transferred to a new tube.  
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Protein concentration of the resulting whole cell protein extract was determined by the 
Bradford method using the Bio-Rad protein assay reagent.    
GST-fusion protein purifications were carried out using batch purification 
essentially as described by Choi et al. (27).  In this study, 3 mg of protein extract was 
brought to a 300 µl final volume using modified H-buffer.  A 20 µl sample was removed 
for immune blot analysis to determine the amount of GST-fusion protein and Ste7 variant 
protein in the “Input” fraction for each pull down assay.  The remaining sample was 
adjusted to 150 mM NaCl and 1% ovalbumin (or BSA) and added to an eppendorf tube 
containing 75 µl packed volume of glutathione agarose beads.  Binding mixtures were 
incubated for 1 hr at 4oC on a roller wheel.  Beads were washed three times by addition 
of 1 ml of modified H-buffer made with 10% glycerol.  After the final wash, beads were 
suspended in 40 µl of 2 x SDS PAGE buffer and boiled for 5’ min.  The protein 
supernatant was subjected to immune blot analysis to determine the amount of GST-
fusion protein and Ste7M variant protein in the “eluant fraction” for each pull down 
assay.  
“Input” and “Eluant” samples were fractionated on duplicate gels by 10% SDS 
PAGE and transferred to nitrocellulose filters.  One of the filters was probed for detection 
of the Ste7M variants using the primary monoclonal anti-myc 9E10 antibodies (2.1 
µg/ml).  The duplicate filter was probed for detection of the GST fusion protein using the 
primary monoclonal anti-GST antibodies (Promega, 1:1,000).  Secondary antibodies for 
both were goat anti-mouse IgG alkaline phosphatase conjugate (Promega, 1:7000).  
Immunoreactive species on the blots were detected by colorimetric methods according to 
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procedures detailed by the Promega Protoblot system.  Signals from the scanned blots 
were quantified using NIH ImageJ software. 
Immune blot conditions for analysis of dual phosphorylated Fus3M and 
Kss1M.  Strains C699-90 (ste5∆ ste7∆ fus3∆ kss1∆) and C699-140 (ste7∆ fus3∆ kss1∆) 
were transformed with plasmids for TPI1 promoted expression of myc tagged Kss1 
(Kss1M, pNC977) and/or myc tagged Fus3 (Fus3M, pNC979).  These two strains were 
also co-transformed with pRS313 and pRS316 to provide references for potential cross-
reacting species.   The resulting strains were then transformed with plasmids for CYC1 
promoted expression either of wild-type Ste7 (pNC318), Ste7-EE-A7 (pNC597) or Ste7-
EE-E7 (pNC893). 
Cultures of each strain were grown in selective medium (-Trp -His and/or -Ura) 
with sucrose (1%) as the carbon source to a density of 5 x 106 cells/ml.  A sample of the 
culture from strain C699-140 expressing wild-type Ste7 was used for the uninduced 
reference.  The remaining portion of this wild-type Ste7 culture was pheromone induced 
by addition of α-factor (50 nM).  Samples were removed at after addition of pheromone 
for comparison of 10 min, 15 min and 20 min induction times.  Cells were harvested by 
centrifugation and suspended in lysis buffer (1 M Tris pH 8.0, 0.4 M (NH4)2SO4, 5 mM 
EDTA pH 8.0, 10% Glycerol, 7 mM β-mercaptoethanol, 1 mM orthovanadate, 1 mM 
PMSF,  5 µg /ml each pepstatin A, chymostatin, antipain, leupeptin, and leupeptin.)  Cell 
lysis, extract preparation and TCA precipitation were done according to procedures 
described by Sabbaugh et al. (156) except for the composition of the lysis buffer.   Pellets 
from TCA precipitation were suspended and adjusted to a protein concentration of  7 
µg/µl in 3X SDS-PAGE loading buffer and boiled for 10 min. 
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Samples were fractionation by SDS-PAGE on duplicate 10% gels and transferred 
to nitrocellulose filters.  One filter was used for detection of the total amount of Fus3M 
and Kss1M using anti-c-myc goat polyclonal antibodies (Santa Cruz) at 0.2 µg/ml with 
rabbit anti-goat alkaline phosphatase conjugated IgG (Santa Cruz) at 0.04 µg/ml.  The 
duplicate filter was used to detect the fraction of dual phosphorylated Fus3M and Kss1M 
using anti-phospho p44/p42 MAP kinase rabbit polyclonal antibodies (Cell Signaling 
Technology) at a 1:500 dilution with goat anti-rabbit alkaline phosphatase conjugated 
IgG (Santa Cruz) at 0.04 µg/ml.   The anti-phospho p44/p42 MAP kinase rabbit 
polyclonal antibodies specifically recognize the dual phosphorylated forms of Fus3 and 
Kss1 (9, 156).  Immunoreactive species were detected by colorimetric methods according 
to procedures detailed by the Promega Protoblot system.  Signals from the scanned blots 
were quantified using NIH ImageJ software. The fold-induction for phospho-Kss1 and 
phospho-Fus3 in each sample was determined by normalizing the ratio of the anti-
p44/p42 signal to the anti-myc signal for each MAPK to the corresponding ratio for the 
uninduced reference sample. 
Immune blot conditions for detection of Ste7 phosphorylation and 
ubiquitination status.  Pheromone induction results in the accumulation of 
hyperphosphorylated Ste7 that has a 10 kD slower SDS-PAGE mobility than 
unphosphorylated Ste7 (187).  To assess SDS-PAGE mobility, Ste7M and different 
substitution variants as specified were expressed from the CYC1 promoter in strain C699-
89 (ste7∆ trp1-1) or C699-106 (ste7∆ trp1∆::HIS3MX6 ).  80 µg of each whole cell 
extract was fractionated by 10 % SDS PAGE and transferred to nitrocellulose.  Ste7M 
and substitution variant proteins were detected by using goat anti-myc antibodies (Santa 
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Cruz) at a 1:1000 dilution with rabbit anti-goat alkaline phosphatase conjugated IgG 
(Santa Cruz) at a 1:10,000 dilution.  Immunoreactive species were detected by 
colorimetric methods according to procedures detailed by the Promega Protoblot system. 
 Ubiquitination of Ste7 results in the formation of a high molecular weight species 
(Ubi-Ste7) (26, 71).  For detection of this species, wild-type Ste7 and Ste7 variant 
proteins were expressed from the STE7 promoter in strain YHD1001 (ste7∆ ubp3∆) or 
from the CYC1 promoter in strain C699-32 (ste7∆) expressing a dominant-negative form 
of Ubp3 (pYES-Ubp3C469S).  Cells were grown to mid-log phase in selective media (-Ura 
or -Trp), treated with 3 µM (YHD1001) or 50 nM (C699-32) α-factor for 1 hr and lysed 
directly in SDS-PAGE buffer for fractionation by 7.5% SDS PAGE and transfer to 
nitrocellulose.  Membranes were developed by using primary anti-Ste7 antibodies at (yN-
18, Santa Cruz) 1:200 dilution and secondary anti-goat IgG conjugated to horseradish 
peroxidase (Santa Cruz) at 1:6000 dilution.  Immunoreactive species were visualized 
using the enhanced chemi-luminescence detection system (Pierce) as directed by the 
vendor. 
Results 
Ste7 phosphorylation site variant proteins.  Pheromone induction leads to 
activation of Ste7 through phosphorylation of two residues at the activation loop of the 
catalytic domain (Figure 2.2A) (49, 128, 183).  Once activated Ste7 phosphorylates and 
activates the downstream MAPKs, either of which mediate feedback 
hyperphosphorylation of Ste7 (187). Using an in vitro reconstitution system with E. coli 
purified components we showed that Fus3 directly phosphorylates both the N- and C-
terminal domains of Ste7 (49).  The evidence in a supplement to this paper 
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(http://mcb.asm.org/.) provides documentation that S105, T116, S130, T136, T149, S167 and 
S471 account for the major sites of Ste7 that are feedback phosphorylated by Fus3 in vitro 
and for the mobility shift of Ste7 that occurs during pheromone induction (Figure 2.2).   
To explore systematically the function and regulation of the different Ste7 
phosphoforms, we constructed a panel of Ste7 variants with substitutions at residues that 
become phosphorylated in the activation loop, feedback sites or both.  Glutamate 
substitutions have negative charge and should mimic phosphorylation whereas alanine 
substitutions preclude phosphorylation and mimic the unphosphorylated state.  Consistent 
with these assumptions, previous evidence established that glutamate substitutions at the 
activation loop residues make Ste7 a constitutively active kinase and that alanine 
substitutions at these residues render Ste7 inactive (49, 183). 
MAPK-dependent hyperphosphorylation of Ste7 causes slow mobility of this species 
on SDS-PAGE (187).  To assess whether glutamate and alanine substitutions at the 
feedback residues similarly confer conformations corresponding to hyper- and 
hypophosphorylated Ste7, respectively, we compared the SDS-PAGE mobility of the 
variants to that of Ste7 from uninduced and pheromone induced cultures (Figure 2.2B and 
C).  A single species with mobility identical to hyperphosphorylated Ste7 was observed 
for any variant with glutamate substitutions at the feedback residues whether or not 
cultures were treated with pheromone (Fig. 2 B and C, Ste7-E7, Ste7-AA-E7 and Ste7-
EE-E7).  Also, regardless of pheromone induction, a single species with mobility identical 
to hypophosphorylated Ste7 was observed for variants with alanine substitutions at the 
feedback residues (Figure 2.2B and C, Ste7-A7, Ste7-AA-A7 and Ste7-EE-A7).  The 
constitutively active and inactive variants with serine and threonine residues at the 
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feedback sites also exhibited mobility on SDS-PAGE that was independent of pheromone 
induction.  Ste7-EE induces Fus3/Kss1 activity and becomes hyperphosphorylated even 
in the absence of pheromone induction.  Ste7-AA fails to stimulate Fus3/Kss1 activity 
above background and remains largely hypophosphorylated even in the presence of 
pheromone induction (Figure 2.2B and C, Ste7-EE and Ste7-AA).  From these 
correlations, we infer that glutamate and alanine substitutions at the feedback residues 
correctly confer conformations corresponding to hyper- and hypophosphorylated Ste7, 
respectively.   
MAPK-mediated feedback regulation of Ste7 activity.  We previously 
observed attenuation of Ste7 activity in cells expressing Fus3 and Kss1 compared with 
cells deficient in both MAPKs (48, 49).  One explanation for the observation is that 
specific activity of Ste7 is lower after feedback phosphorylation than before modification.  
To test this hypothesis, we compared in vitro kinase activity of the variant that cannot be 
phosphorylated at the feedback sites (Ste7-A7) to that of wild-type Ste7 and catalytically 
inactive Ste7-R220.  For this comparison, myc epitope tagged Ste7, Ste7-A7 and Ste7-R220 
proteins were expressed from the CYC1 promoter and immune precipitated from extracts 
of uninduced or pheromone induced cells either expressing Fus3 and Kss1 (FUS3 KSS1) 
or deficient in both MAPKs (fus3∆ kss1∆).  Assays were done directly in immune 
complexes using 32P-γ-ATP with catalytically inactive Fus3 (Fus3-R42) as the protein 
substrate.  Contrary to our prediction, Ste7-A7 has lower activity than the wild-type 
reference (Ste7) (Figure 2.3A lanes 5, 6). Activity of Ste7-A7 is higher when isolated 
from fus3∆ kss1∆ cells compared with the FUS3 KSS1 cells (Figure 2.3A, lanes 6 and 9). 
This activity is still lower than the wild-type reference in this background (Figure 2.3A, 
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lanes 8 and 9).  These findings show that MAPK dependent suppression of Ste7 activity 
occurs through a mechanism that is distinct from MAPK catalyzed Ste7 feedback 
phosphorylation. 
Fus3 and Kss1 mediated signal attenuation mechanisms that target components 
upstream of Ste7 could diminish accumulation of active Ste7.  For example, the 
MAPKKK-Ste11 is targeted for MAPK and ubiquitin-dependent degradation during 
pheromone induction (51).  Consequently, a greater fraction of Ste7 can be activated in a 
fus3∆ kss1∆ background compared with the FUS3 KSS1 background because active 
Ste11 can accumulate in the former but not the latter (51).  According to this model the 
kinase activity of constitutive Ste7 variants should be independent of Fus3 and Kss1 
genetic background because they do not require modification by an upstream component 
for their activation.  Therefore, we compared in vitro kinase activity of constitutive Ste7 
derivatives that can and cannot be feedback phosphorylated using immune complex 
kinase assays as before. 
As expected for a constitutive enzyme, Ste7-EE isolated from cultures without 
pheromone induction readily catalyzes phosphorylation of catalytically inactive Fus3 
(Fus3-R42) (Figure 2.3B, lane 2).   The effect of pheromone induction on activity of the 
constitutive enzymes is minimal when isolated from either FUS3 KSS1 or fus3∆ kss1∆ 
cells (~2-fold or less) (Figure 2.3B, compare lanes 2 -3 to 6-7 and lanes 4-5 to 8-9).   
Constitutive Ste7 that is hyperphosphorylated (Ste7-EE) has higher activity than non-
feedback phosphorylated constitutive Ste7 (Ste7-EE-A7) (Figure 2.3B, compare lanes 2, 
and 6 to lanes 3-5, 8, and 9).  As seen with wild-type Ste7, feedback phosphorylation has 
a positive effect on the ability of constitutive Ste7 to phosphorylate Fus3-R42 in vitro.  
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The comparisons made with Ste7-EE-A7, which eliminates the effect of feedback 
phosphorylation, show that constitutive Ste7 has essentially the same activity regardless 
of pheromone induction and of FUS3 KSS1 genetic background (Figure 2.3B. compare 
lanes 3, 5, 7 and 9).  This outcome is consistent with the assessment that MAPK-
dependent suppression of wild-type Ste7 activity occurs through attenuation mechanisms 
that target upstream components of the mating pathway.   
Based on the above model, we infer that much of the Ste7 isolated from 
pheromone induced FUS3 KSS1 cultures is still in the inactive state.  Therefore, the 
amount of Fus3-R42 phosphorylation catalyzed by enzymes isolated from pheromone 
induced fus3∆ kss1∆ cultures should be used to assess their relative specific activities. 
Using this criterion, the specific activity of Ste7 with glutamates at the activation loop is 
only10-15% of that for Ste7 activated by phosphorylation (Figure 2.3A and B lanes 8 and 
9).  Yet, the amount of Fus3-R42 phosphorylation catalyzed in these in vitro reactions by 
constitutive Ste7 is similar to that for wild-type Ste7 isolated from pheromone induced 
FUS3 KSS1 cultures (Figure 2.3B lanes 1, 2, and 6).  Thus despite low specific activity, 
expression of constitutive Ste7 from the CYC1 promoter yields a total activity 
comparable to what is achieved by the fraction of wild-type Ste7 that becomes activated 
during pheromone induction. 
MAPK-mediated feedback regulation of Ste7 ubiquitination. Recent studies 
revealed that Ste7 undergoes SCF- (Skp1/Cullin/F-box) dependent ubiquitination and 
proteosome-mediated degradation upon prolonged stimulation by pheromone (26, 71).  
To examine whether feedback phosphorylation or constitutive activity preferentially 
targets Ste7 for ubiquitination, we expressed wild-type Ste7 and different 
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phosphorylation site variants from their own promoter in a mutant strain background 
known to accumulate ubiquitinated Ste7 (ubp3∆)(26, 71).  The ubiquitin-modified protein 
accumulates for wild-type Ste7 and for derivatives with serine and threonine at the 
activation loop regardless of what residues are present at the feedback sites (Figure 2.4A, 
lanes 1-3).  The ubiquitin-modified species fails to accumulate for derivatives with either 
alanines or glutamates at the activation loop (Figure 2.4A. lanes 4-5 and 8-10).  
Therefore, the ubiquitin modification of Ste7 is dependent on phosphorylation at the 
activation loop but is independent of the feedback phosphorylation status of Ste7. 
The failure to accumulate ubiquitinated Ste7 when glutamates occupy the 
activation loop sites could be explained if glutamates are an inadequate mimic for 
phosphorylated residues with regard to recognition by the ubiquitination machinery.   
Alternatively, signal output from the mating pathway may be critical to the mechanism 
for Ste7 ubiquitination.  We learned that the glutamate substitution variants expressed 
from the endogenous STE7 promoter are functional for invasive growth but not for 
mating.  However, overexpression of Ste7-EE-A7 from the CYC1 promoter restores some 
level of mating pathway output. (See below).   To test the idea that signal output is 
critical for ubiquitination, we compared wild-type Ste7 and Ste7-EE-A7 when expressed 
from the CYC1 promoter for ubiquitination in ste7∆ and ste7∆ ste11∆ strains.  Both 
strains also expressed a dominant negative form of Ubp3 (Ubp3C469S) to allow 
accumulation and visualization of ubiquitinated species as before.  Ubiquitinated-Ste7 
and ubiquitinated-Ste7-EE-A7 are detected in the ste7∆ strain (Figure 2.4B, lanes 2 and 
3).  However, the ratio of the ubiquitinated species to the unmodified species for Ste7-
EE-A7 (0.08) is markedly less than that for the pheromone induced wild-type Ste7 
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reference (0.31). The comparison in the ste7∆ ste11∆ strain is striking because Ste7-EE-
A7 becomes ubiquitinated in the absence of pheromone treatment and under conditions 
where wild-type Ste7 remains unmodified (Figure 2.4B lanes 5 and 6).   The fraction of 
ubiquitinated Ste-EE-A7 (0.21) under these conditions is comparable to that for the 
pheromone induced wild-type reference (0.31) (Figure 2.4B lanes 2 and 6).  These results 
establish that Ste7 variants with glutamates at the activation loop are competent 
substrates for ubiquitination and that signal output from the pathway is required for the 
modification.  
Mating response and invasive growth phenotypes of Ste7 phosphorylation 
site variants.  Ste7 mediates mating differentiation and invasive growth in haploid S. 
cerevisiae.  To determine if expression of constitutive Ste7 and feedback phosphorylation 
influences the establishment of one or the other of these fates, we quantified mating and 
invasive phenotypes of strains expressing the different variants.   For evaluation of 
mating pathway function, strains were compared for mating efficiency and pheromone 
induced transcriptional, G1-arrest, and morphological responses (Figure 2.4).  A strain 
expressing a Ste7 variant (Ste7-N349) that is inactive because of an Asn substitution for a 
catalytically essential Asp residue was included as a negative control for these 
comparisons. As expected for catalytically inactive enzymes, the variants with Ala 
substitutions at the activation loop (Ste7-AA, Ste7-AA-E7, Ste7-AA-A7) failed to mate 
and to support pheromone induced responses (Figure 2.5A-C).  The variants with Ser and 
Thr at the activation loop support mating independently of the charge status of the 
feedback phosphorylation residues (Figure 2.5A, Ste7, Ste7-E7, Ste7-A7).  These variants 
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also function similarly with respect to the pheromone-induced reporter gene expression, 
G1-arrest, and mating projection formation (Figure 2.5B and C).   
Despite constitutive in vitro kinase activity, the variants with glutamate 
substitutions at the activation loop fail to support mating, transcriptional, G1-arrest, and 
morphological responses to pheromone (Figure 2.5 A-C, Ste7-EE, Ste7-EE-E7, Ste7-EE-
A7).  The defective responses do not depend on which residues occupy the feedback sites.  
Therefore, it appears that the constitutive negative charge at the activation loop underlies 
the failure of these variants to support a mating response.  We further infer that the 
problem must arise at the level of maintaining signal output because Ste7-EE causes 
sufficient activation of Fus3 and/or Kss1 in vivo to promote phosphorylation of the 
feedback residues (Figure 2.2B, lane 5).    
To examine the function of Ste7 phosphorylation site variants in the filamentous 
growth pathway, each variant was expressed in a ste7∆ strain derived from a background 
(Σ1278) that is competent for pseudohyphal and invasive growth.  Cells were cultured 
using complex medium in chambers that allow direct microscopic visualization of 
colonies as they invade and grow beneath the agar surface (Figure 2.6A).  To quantify 
this response, we calculated the mean area of individual colonies below the agar surface.  
The average of the mean colony area from three independent experiments is shown 
(Figure 2.6B).   
Strains expressing the Ste7 variants with inducible activity invaded the agar 
substrate and grew into colonies with pseudohyphal filaments at the periphery (Figure 
2.6A, Ste7, Ste7-A7, Ste7-E7).  As expected, strains expressing the catalytically inactive 
Ste7 variants invaded the agar poorly (Figure 2.7A, Ste7-N349 and Ste7-AA).  There were 
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few invasive colonies in these cultures and those that formed below the agar surface were 
in general smaller than those of the wild-type reference (Figure 2.6B).  Also, the invasive 
colonies of the strains with inactive Ste7 did not elongate or form filaments as did the 
colonies from strains with active Ste7. (See supplemental data, http://mcb.asm.org/.)   In 
contrast to their null mating phenotype, the constitutive Ste7 variants support invasive 
growth (Figure 2.6A, Ste7-EE, Ste7-EE-A7, Ste7-EE-E7).  Indeed, the invasive colonies 
of strains expressing the constitutive variants have a larger mean area than strains 
expressing inducible Ste7 (Figure 2.6B).  They also have a hyper-filamented phenotype 
relative to the wild-type reference. (See also supplemental data, http://mcb.asm.org/.) 
The above comparison shows that the constitutive Ste7 variants are functional 
under in vivo conditions and eliminates trivial explanations for their defective mating 
response phenotypes.  Also, the failure to function in the mating pathway cannot be 
solely a function of strain background because the constitutive variants are defective for 
mating responses in the same Σ1278 strain that was used for these invasion assays 
(Figure 2.5B and C).  Therefore, these observations establish that constitutive Ste7 
uniquely specifies a filamentous growth response.   
Constitutive Ste7 phosphorylates Kss1 but not Fus3 in vivo.  Although constitutive 
Ste7 variants are functional kinases in vitro (Figure 2.3), it is possible that their activity is 
insufficient to support high levels of active MAPK.  In this case the observed signal 
specificity could simply be that a lower threshold of MAPK activation is needed for the 
invasion response than for the mating response.  To examine this possibility, we used 
immune blot detection methods to compare the fraction of phosphorylated Fus3 and Kss1 
that is sustained in vivo by constitutive Ste7 (Ste7-EE-A7 or Ste7-EE-E7) to that achieved 
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by wild-type Ste7 during pheromone induction (9, 156).  Myc-epitope tagged Fus3 
(Fus3M) and Kss1 (Kss1M) were expressed from the constitutive TPI1 promoter in the 
strains used for this comparison.  Because endogenous Fus3 (but not Kss1) expression is 
induced by pheromone, their expression from the TPI1 promoter ensured equivalent 
transcription of the two MAPKs independently of a mating pathway-induced response 
(42).  Extracts of the different cultures were fractionated on duplicate gels by SDS-
PAGE, which resolves Kss1 and Fus3, and transferred to nitrocellulose for immune blot 
analysis.  Anti-myc antibodies were used on one filter to determine the total amount of 
Fus3M and Kss1M in each extract.  The duplicate filter was used to detect the amount of 
dual phosphorylated (pT-E-pY) Fus3M and Kss1M using anti-phospho Erk antibodies (9, 
156).  
Normal pheromone induction leads to an increase in the relative amount of dual- 
phosphorylated Fus3 and Kss1 (17, 156).  Extracts of cultures expressing either Ste7-EE-
A7 or Ste7-EE-E7 without pheromone induction were compared directly to those from the 
uninduced (t=0) and pheromone induced (t=15 min) wild-type Ste7 reference (Figure 
2.7A).  Constitutive Ste7 promotes in vivo phosphorylation of Kss1 to levels that are as 
high or higher than seen for the pheromone-induced reference (Figure 2.7A and D).  By 
contrast, there is no increase in Fus3 phosphorylation above the basal levels seen for the 
uninduced reference (Figure 2.7A and D).  We also examined Kss1M phosphorylation 
when co-expressed with Ste7-EE-A7 or Ste7-EE-E7 in the absence of Fus3.   We find that 
constitutive Ste7 promotes levels of phospho-Kss1 that are lower in the absence than in 
the presence of Fus3.  But the amount of phospho-Kss1 is nevertheless comparable to the 
pheromone-induced levels (Figure 2.7A, lanes 4, 5, 7, 8 and 7D).  The amount of 
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phospho-Fus3 remained at the basal levels seen for the uninduced reference whether or 
not Kss1 was also present (Figure 2.7A and D).  Similar results were seen with extracts 
from the corresponding ste5∆ strains (Figure 2.7B, C and D).   These results show that 
the ability of constitutive Ste7 to phosphorylate Kss1 is independent of the scaffold-Ste5.  
They also suggest that Fus3 has some positive role in allowing hyper-accumulation of 
phosphorylated Kss1.  The finding that constitutive Ste7 promotes high levels of 
phospho-Kss1 rules out the possibility that the substitution variants of Ste7 are ineffective 
kinases in vivo.  Further, the activation of Kss1 is consistent with the observed 
stimulation of an invasive response by constitutive Ste7.  
We did not anticipate the finding that constitutive Ste7 would phosphorylate Kss1 but 
not Fus3 in vivo.  This outcome brings up two questions.  What mechanisms contribute to 
the selective activation of Kss1 and what suppresses the mating response expected from 
the activation of Kss1?   We address each of these issues by the experiments below. 
Phosphorylation status of Ste7 determines its selective binding to components 
of the MAPK activation module.  To delineate how constitutively active Ste7 
selectively phosphorylates Kss1 in vivo, we compared Ste7 variants for relative binding 
to each of the relevant components of this pathway using a standard GST-fusion protein 
co-purification assay.  We limited the comparison to those variants that represent the four 
possible combinations of loop and feedback site phosphorylation states of Ste7 (Ste7-
AA-A7, Ste7-EE-A7, Ste7-AA-E7, and Ste7-EE-E7).  This selection was made to insure 
that the population of Ste7 species in different binding reactions would be homogenous 
and unaffected by the spurious action of phosphatases or kinases.  Additionally, the 
substitution variants allow assessment of interactions with species of Ste7 that would 
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otherwise be transient and thus of too low abundance to be detected in comparisons of 
wild-type Ste7 from uninduced and pheromone induced extracts. 
A host strain that is deficient in all MAPK module components (ste5∆ ste11∆ 
ste7∆ fus3∆ kss1∆) was used so that only pair wise interactions would be assessed.  (The 
exception was for comparisons of Ste7 binding to GST-Ste5.  See below.)  The GST-
fusion proteins and the myc-tagged Ste7 variant proteins in the input and eluant fractions 
of these assays were detected by using anti-GST antibodies and anti-myc antibodies, 
respectively (Figure 2.8, A-E).  Relative binding efficiencies are reported as the ratio of 
the anti-myc signal to the anti-GST signal in the eluant fraction.  Because there is no 
binding of Ste7 variants to GST alone, the presence of Ste7 in an eluant fraction is due to 
its binding to the specified MAPK pathway component (Figure 2.8E).  For reference, the 
magnitude of the relative binding of Ste7-AA-A7 to each of the GST-fusion proteins 
reported below is the same or slightly greater than what we observed for wild-type Ste7 
in the corresponding strains (data not shown.) 
We failed to detect a binding interaction between GST-Ste5 and Ste7 (or any 
substitution variant) when the proteins were co-expressed in the strain deficient in the 
scaffold and all the core enzymes of the MAPK activation module.  The failure to detect 
a complex is consistent with published two-hybrid studies that found the Ste7-Ste5 
interaction was substantially lower in a strain lacking endogenous Ste5 (27).  
Additionally, the published co-purification assay for wild type Ste7 and GST-Ste5 used a 
strain deficient only in Ste11 and Fus3.  We suspect that endogenous Ste5 oligomerizes 
with GST-Ste5 and provides some essential binding function that is missing for the GST-
fusion protein.  Therefore, we used the analogous strain (ste11∆ fus3∆) to co-express 
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GST-Ste5 with the different Ste7 variant proteins.   Under these conditions we found that 
Ste7-AA-A7, Ste7-EE-A7, and Ste7-AA-E7 bind equally well to Ste5 but Ste-EE-E7 binds 
less effectively (Figure 2.8A).  The latter observation is consistent with the report that 
hyperphosphorylated wild-type Ste7 binds poorly to Ste5 (27).  However, the inactive but 
hyperphosphorylated Ste7 variant (Ste7-AA-E7) binds to Ste5 as well as the variants 
without charge at the feedback phosphorylation sites.   To reconcile this observation with 
that of Choi et al. (27), we assume that inactive but hyperphosphorylated Ste7 is a minor 
species in the wild-type population. The relatively poor binding of Ste7-EE-E7 to Ste5 
could contribute to inefficient co-localization with Fus3.  This deficiency could explain 
the failure of Ste7-EE-E7 to phosphorylate Fus3 in vivo.  However, we note that Ste7-EE-
A7 binds well to Ste5 even though this variant also fails to phosphorylate Fus3 in vivo 
(Figure 2.7).  These results suggest that simply tethering Ste7 on the scaffold is not 
sufficient to insure effective phosphorylation of Fus3. (See below.)  
All four Ste7 phosphorylation site substitution variants bind to the MAPKKK-
Ste11 (Figure 2.8B).  In principle, the binding of Ste11 to constitutive forms of Ste7 
could negatively affect signaling by competing with the MAPKs for access to Ste7.  
However, it is unclear whether this potential competition would be significant in the 
scaffold-organized complex.   
The most surprising finding is that the phosphorylation state dependence of Ste7 
binding to the MAPK-Fus3 is different from that for binding to the MAPK-Kss1.  All 
four Ste7 phosphorylation site substitution variants bind similarly to Kss1 (Figure 2.8D).  
By contrast, the strongest binding to Fus3 was seen with Ste7-AA-A7, which represents 
inactive Ste7 without feedback phosphorylation (i.e. naïve Ste7) (Figure 2.8C).  Ste7-EE-
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A7 essentially showed no binding to Fus3 (Figure 2.8C).  This variant can be thought of 
as the “transition state intermediate” on the pathway from active Ste11 to active Fus3 and 
Kss1.  The failure of this intermediate to bind to Fus3 reveals that the scaffold-Ste5 
probably provides the major route for co-localizing active Ste7 with Fus3.  The binding 
characteristics of the different Ste7 variants are also consistent with Ste5 being 
dispensable for the activation of Kss1 by Ste7. 
Constitutive Ste7 variants promote high levels of filamentation-specific 
reporter gene expression.   Invasive growth and Kss1 activation promoted by 
constitutive Ste7 predicts that these variants should stimulate filamentation-specific gene 
expression above the basal levels seen in a wild-type Ste7 background.  To confirm this 
prediction, we measured expression of a filamentation-specific reporter gene in ste7∆, 
ste7∆ fus3∆, and ste7∆ kss1∆ strains that expressed Ste7 and variant proteins from the 
CYC1 promoter.  The reporter gene (Ty-LacZ) for this comparison uses a Tec1-Ste12 
composite binding site derived from the Ty1 sequence to drive LacZ expression (Figure 
2.1) (12).  
Consistent with this prediction, constitutive Ste7 variants promote 9- to 20-fold 
higher β-galactosidase activity relative to the amount promoted by the wild-type Ste7-
reference (Table 2.3, Row 1 Col B-E).  In a strain deficient in the MAPK-Kss1, reporter 
gene activity remains at background amounts whether or not the strain expresses wildtype 
or constitutive Ste7 variants (Table 2.3, Row 3, Col B-F).  This outcome is consistent 
with the effects of constitutive Ste7 being mediated by phosphorylation and activation of 
Kss1.  Deleting the mating-pathway specific MAPK-Fus3 significantly enhances Τy-
LacZ expression promoted by the wild-type Ste7 but not by constitutive Ste7-variants 
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(Table 2.3, Row 2, Col B-E).  The negative effect that Fus3 has on Ty-LacZ expression in 
the wild-type Ste7 strain is consistent with previously reported findings (9, 117, 156, 
181).   The finding that Fus3 has no dramatic effect on output from constitutive Ste7 
variants could be either because Fus3 does not accumulate in the activated state in these 
strains or because hyperactivation of Kss1 is sufficient to overcome any negative effects 
that active Fus3 mediates. 
The negative effect that Fus3 has on the transcriptional output for wild-type Ste7 
is also apparent for the invasion phenotype. Using the same assay as before, we find the 
average invasion colony area for wildtype Ste7 is ~ 3-fold greater in the fus3∆ strain 
compared with the FUS3 strain (Figure 2.9).  The constitutive Ste7 variants also show a 
more robust invasion phenotype in fus3∆ strains compared with FUS3 strains (Figure 
2.9).   This result shows that Fus3 has a more negative effect on invasion compared with 
the Ty-LacZ reporter gene expression.  We infer that other branches of the pseudohyphal 
network (and/or downstream events required for invasion) are more sensitive than the 
transcriptional output to inhibitory effects of Fus3.  
Overexpression of Ste7-EE-A7 in strains deficient in Fus3 and Ste5 promotes 
high levels of mating-specific gene expression.   Although Fus3 and Kss1 have non-
overlapping roles in the mating response, they are largely equivalent with respect to 
activating the pheromone induced mating transcription program (17, 181).  Therefore, 
constitutive Ste7, which potently activates Kss1, is expected to promote mating specific 
gene expression.   The failure to do so suggests the existence of inhibitory mechanisms 
that selectively block activation of mating specific genes under conditions of persistent 
Kss1 activation.  There have been various studies revealing different circumstances 
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where Fus3 and Kss1 have inhibitory effects on gene expression (9, 32, 54, 117, 170, 
181).  These reports prompted us to test whether deletions of MAPK activation module 
components might rescue the ability of constitutive Ste7 to promote mating-specific gene 
expression.  
To make this test, wild-type and constitutive Ste7 variants were expressed from 
the CYC1 promoter in ste7∆ strains that also had deletions of other MAPK activation 
module components.  β-galactosidase activity was measured to assess pheromone 
independent activation of a mating pathway reporter gene (FUS1-LacZ). This reporter 
uses the previously described upstream activating sequence from the FUS1 promoter that 
encompasses three Ste12 binding sites to drive LacZ expression (Figure 2.1) (47).  
Pheromone treated ste7∆ FUS3 KSS1, ste7∆ fus3∆ KSS1, and ste7∆ FUS3 kss1∆ cultures 
expressing wild-type Ste7 were included in the comparison to establish reference values 
for induced reporter gene activation in the three different MAPK genetic backgrounds.   
Pheromone treatment of a wild-type strain causes a 3000-fold increase in reporter 
gene expression compared with the reference strain lacking Ste7 (Table 2.3 Row 4 Col A 
compared with Col G).  Only the constitutive Ste7 variant that cannot be feedback 
phosphorylated (Ste7-EE-A7) promoted FUS1-lacZ expression above the background 
amount (Table 2.3, Row 4 Col C and Col F).   Deletion of certain components of the 
MAPK activation cascade further enhanced this activity.  Eliminating the MAPK-Fus3 or 
the MAPKKK-Ste11 allowed significant enhancement of Ste7-EE-A7 promoted reporter 
gene expression above that in the otherwise wild-type background (Table 2.3, Col C 
Rows 6 and 7 compared with Row 4).  These findings show that Ste11 and Fus3 are 
negative regulators of constitutive mating pathway transcription. Ste7-EE-A7 failed to 
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promote reporter gene expression above background amounts in the corresponding strains 
expressing Fus3 but lacking Kss1 (Table 2.3, Col C Rows 11-13).  This outcome 
corroborates the finding that Ste7-EE-A7 fails to phosphorylate and activate Fus3 in vivo 
(Figure 2.7).  This outcome further shows that Kss1 is the sole mediator of any 
transcriptional response promoted by Ste7-EE-A7.  
The most striking finding was that Ste5 and Fus3 synergistically mediate 
inhibition of mating-specific gene expression.  Eliminating both Ste5 and Fus3 allowed 
Ste7-EE-A7 to promote reporter gene expression that was ~5-fold higher than that seen 
for pheromone induced Ste7 in the fus3∆ reference strain (Table 2.3, Col C Row 9 
compared with Col A Row 7).  This synergism is not a simple consequence of deleting 
two components with negative effects because eliminating Ste11 and Fus3 or Ste5 and 
Ste11 has no greater effect than eliminating Ste11 alone (Table 2.3, Col C Rows 6, 8 and 
10).  These findings suggest that the scaffold-Ste5 and the MAPK-Fus3 collaborate in a 
mechanism that restricts mating pathway output under conditions of persistent Kss1 
activation.  This collaborative mechanism is notable because these are the two 
components that distinguish the mating pathway from the invasive growth pathway.   
We observed that constitutive Ste7 variants with and without charge at the 
feedback sites promote comparable levels of phospho-Kss1 (Figure 2.7).  Thus, it is 
perplexing that the constitutive variants with negative charge at the feedback sites (Ste7-
EE or Ste7-EE-E7) remained defective for promoting FUS1-lacZ expression even in the 
deletion strains that expose activity promoted by Ste7-EE-A7 (Table 2.3, Cols C-E 
compared with Col F).  This outcome points to an inhibitory mechanism imposed by 
Ste7-EE-E7 that is independent of Fus3 and Ste5.  Thus two distinct mechanisms act to 
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selectively block transcription from mating specific genes.  Whether the Ste5 and Fus3 
mediated mechanism or Fus3 and Ste5 independent-mechanism is predominant depends 
on whether constitutive Ste7 is without or with charge at the feedback sites.  The 
potential relevance for the existence of two different inhibitory mechanisms is discussed 
below.  
Discussion 
 
Ste7 is the MAPKK in pathways mediating two distinct developmental programs 
in haploid S. cerevisiae: mating differentiation and invasive (or filamentous) growth.  By 
using substitution variants of Ste7 with constitutive activity we learned that pathway 
discrimination occurs independently of distinguishing external stimuli.  Constitutive Ste7 
completely fails to support mating but promotes an invasive response.  This biological 
outcome is consistent with the finding that constitutive Ste7 promotes phosphorylation of 
the filamentous growth pathway MAPK-Kss1, but not the mating pathway specific 
MAPK-Fus3 in vivo.    Based on patterns of reporter gene expression, it appears that 
persistent activation of Kss1 stimulated by constitutive Ste7 selectively specifies a 
transcriptional program for invasive growth. 
Constitutive Ste7 selectively activates Kss1.   We find a direct correlation 
between phospho-MAPK levels in vivo and the ability of different constitutive Ste7 
variants to bind to Fus3, Kss1 and Ste5 (Table 2.4).  The correlations suggest that 
activation of Fus3 in vivo requires binding to both Ste7 and the scaffold-Ste5 but that 
activation of Kss1 is independent of Ste5.  Constitutive Ste7 with or without negative 
charge at the feedback sites (Ste7-EE-E7 and Ste7-EE-A7) promotes accumulation of 
phospho-Kss1 in vivo independently of Ste5.  Also, both Ste7-EE-E7 and Ste7-EE-A7 
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bind well to Kss1.  Neither Ste7-EE-A7 nor Ste7-EE-E7 promotes accumulation of active 
phospho-Fus3 in vivo.   Ste7-EE-A7 binds to Ste5 but does not bind to Fus3.   Ste7-EE-E7 
binds to Fus3 but interacts poorly with Ste5.  Taking mass-action into account, we expect 
the equilibrium distribution of Ste7-EE-E7 expressed from either from the CYC1 or 
endogenous promoter would favor a pool that is localized away from the Ste5 complex.  
Thus, both forms of constitutive Ste7 miss one or the other of the two binding 
interactions that we postulate is crucial for efficient Fus3 phosphorylation and activation.  
Observations in the literature support this proposed difference in the way Ste7 
activates Kss1 compared with Fus3.  Using constitutively active Ste11, Andersson et al. 
(3) showed that Ste5 is essential for Fus3 activation but dispensable for Kss1 activation.  
Bardwell et al. (7) showed that direct binding of Ste7 to Fus3 cooperates with the scaffold 
protein to enhance signal transmission.  In addition to these binding interactions, a 
specific stereochemical orientation of Fus3 and Ste7 on the scaffold appears to be 
important for optimal activation of Fus3 and mating responses.  Park et al. (137) showed 
that Fus3 activation is 5- to 10- fold lower than normal and mating efficiencies are two to 
three logs lower than normal when Fus3 or Ste7 are tethered at an artificial site through a 
PDZ domain binding at the C-terminus of Ste5.  
The differential amounts of active Kss1 and Fus3 reflect not only differences in 
their phosphorylation by constitutive Ste7 but also potential differences in 
dephosphorylation by phosphatases.  Msg5 is a dual specificity MAPK phosphatase that 
regulates Fus3 and Kss1 through dephosphorylation of the phospho-tyrosine and 
phospho-threonine residues at their activation loop (35, 37).  Andersson et al. (3) recently 
reported that Msg5 selectively inhibits Fus3 under basal conditions where signal intensity 
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is low.   Therefore, it is likely that Msg5 contributes to maintaining low basal levels of 
phopsho-Fus3 under conditions of inefficient activation by the constitutive Ste7 variants.  
Implications for Ste7 function on the Ste5-scaffold during pheromone 
induced signaling.   Constitutive Ste7 variants with or without negative charge at the 
feedback sites (Ste7-EE-E7 and Ste7-EE-A7) are defective for activating Fus3 and 
sustaining mating responses.  By contrast, their counterparts that have serine and 
threonine residues at the activation loop (Ste7-E7 and Ste7-A7) function indistinguishably 
from wild-type Ste7 and, therefore, must efficiently activate Fus3 in vivo.  We conclude 
from this contrasting behavior that the glutamate substitutions at the activation loop and 
not the phosphorylation status of Ste7 feedback sites are responsible for the failure of the 
constitutive variants to activate Fus3.   
A higher specific activity of phospho-Ste7 compared with the glutamate-mimic 
could explain different efficiencies of Fus3 activation in vivo.  Yet, differences in specific 
activity of the inducible and glutamate derivatives have little effect on levels of Kss1 
activation in vivo.  Therefore, we believe a more important consideration is whether a 
Ste7 variant can function properly on the scaffold to phosphorylate Fus3.  In contrast to 
the active Ste7 mimics, Ste7-AA-A7 (which mimics naïve Ste7) and Ste7-AA-E7 (which 
mimics feedback phosphorylated but inactive Ste7) efficiently bind to both Fus3 and 
Ste5.  Thus, the requirements for function on the scaffold could be satisfied for Ste7-A7 
and Ste7-E7 in their naïve state or after dephosphorylation at the activation loop.  The 
failure of glutamate substitution counterparts to activate Fus3 could be viewed as a 
consequence of their being impervious to phosphatases and thus unable to achieve the 
correct sterochemical orientation for activation of Fus3 on the scaffold.    
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This interpretation for function of phospho-Ste7 compared with the glutamate-
mimic suggests the following model for activation of Fus3 during normal pheromone 
induction (Figure 2.10).  We propose that pheromone stimulates the recruitment of 
inactive Ste7 and other of the core enzymes of the mating pathway cascades to the 
scaffold complex for activation by upstream components (Figure 2.10A).   This 
recruitment allows Ste7 to make the contacts with Ste5 and Fus3 that are necessary for 
the correct stereochemical orientation of the scaffold assembly (Figure 2.10B).  This 
configuration is compatible with Ste11 activation of Ste7 and subsequent efficient 
activation of Fus3.  Upon MAPK activation, feedback phosphorylation of active Ste7 
promotes its dissociation from the scaffold (Figure 2.10C).  An implication of this model 
is that continuous recruitment of naïve Ste7 to the scaffold or action of a Ste7 
phosphatase would be critical for sustaining the ability of Ste7 to continue activating 
Fus3.   
The precedent for positive regulation of MAPK activation by a phosphatase 
comes from genetic studies of photoreceptor development in D. melanogaster and vulval 
development in C. elegans (165, 177).  The first indication that PP2A is positive 
regulator in the C. elegans pathway came from the discovery that mutation of a PP2A B-
targeting subunit (sur-6) reduces vulval induction (165).  We similarly observed that 
pheromone-induced MAPK activation is impeded by mutation of the Tap42 targeting 
subunit for PP2A (A. Scott and B. Errede, unpublished). Except for the subset of targets 
involved in stress regulation, Tap42 is a positive regulator of PP2A mediated signaling 
(26, 41).  These observations suggest that a PP2A family enzyme may be a positive 
regulator of the mating pathway MAPK cascade in yeast and provide some support for 
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the proposal that dephosphorylation is one route to sustaining Fus3 activation in the 
scaffold organized complex. 
 Constitutive Ste7 promotes invasion and a filamentation specific 
transcriptional output.  Genome wide expression profiles of pheromone induced strains 
deficient in either Fus3 or Kss1 provide evidence that either MAPK is sufficient to 
promote the mating transcriptional program through activation of Ste12 (17, 149).  
However, the two MAPKs have different effects on Ste12-mediated induction of the 
filamentation transcription program (181).  The kinase activity of Fus3, but not Kss1, 
prevents Ste12 from binding to filamentation-specific genes in pheromone-stimulated 
cells (117, 156, 181).  The inhibitory effects of Fus3 at these promoters are dependent on 
Tec1 (117, 156, 181).  Our analyses suggest the existence of at least two reciprocal 
mechanisms that prevent Ste12 from acting at mating-specific genes under conditions 
that otherwise promote an invasive growth response.  
The finding that overproduction of the constitutive Ste7 without feedback 
phosphorylation (Ste7-EE-A7) restored expression of a mating pathway reporter gene 
opened avenues for us to identify components that suppressed Kss1 mediated activation 
at these promoters.  The comparison revealed that Ste7-EE-A7 in a ste5∆ fus3∆ double 
mutant background promotes levels of FUS1-lacZ that are even greater than what is 
typically seen for a pheromone induced wild-type reference strain (Table 2.3 and 2.4).  
While essential for mating responses, Ste5 and Fus3 are not required for the invasive 
response (150).  Thus it appears these mating pathway-designated components can limit a 
mating response under conditions where Kss1 accumulates in the active form but Fus3 
activity remains at basal levels.  The pool of inactive Fus3 could interfere with active 
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Kss1 by binding to common downstream targets such as the Ste12-Rst1/2 (Dig1/2) 
transcription complex (9, 32, 44, 117, 170).  Alternatively, the basal activity of Fus3 
could be sufficient to modify components of the mating-specific promoter complex in 
way that prevents activation at these promoters.  Although there is no evidence for the 
scaffold-Ste5 participating in either process, such a role would explain the synergistic 
effect of eliminating both Fus3 and Ste5. 
Ste7-EE-A7 is essentially equivalent to Ste7-EE-E7 with respect to promoting 
Kss1 activation and filamentation specific gene expression.  But the mechanism 
responsible for suppression of mating-specific gene expression is different for the two 
constitutive Ste7 variants.  In contrast to the outcome for Ste7-EE-A7, there is no 
activation of FUS1-LacZ expression promoted by Ste7-EE-E7 in the ste5∆ fus3∆ 
background (Tables 2.3 and 2.4).  This result rules out a Fus3 and Ste5 mediated 
mechanism as the sole means for transcriptional suppression at mating-specific promoters 
in strains expressing Ste7-EE-E7.  We speculate that a separate Ste7-EE-E7-dependent 
effect predominates in this circumstance and that it may involve a binding and/or 
substrate specificity that pertains only to active Ste7 with charge at the feedback sites.  
For example, because of this postulated specificity, Ste7-EE-E7 might modify the 
localization or activity of yet to be identified targets that mediate the inhibition at mating-
specific genes. 
The Ste5 and Fus3 dependent and independent mechanisms for suppressing 
transcription at mating-specific promoters may be important under different physiological 
conditions where one or the other feedback forms of Ste7 predominant.  For example, 
Ste5 and Fus3 may contribute to maintaining a low transcriptional output from the mating 
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pathway under basal conditions where feedback phosphorylated Ste7 does not 
accumulate.  By contrast, suppression mediated by the Ste5 and Fus3 independent 
mechanism maybe more important for inhibiting mating output when the invasive 
pathway is stimulated and there is likely to be a persistent and high level of active and 
feedback phosphorylated Ste7.
  
     Table 2.1.  S. cerevisiae strains. 
Strain Genotype Source  or 
Reference 
aC699 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 
 
K. Nasmyth 
C699-5 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG 
 
(51) 
C699-15 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
 
This work 
C699-31 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste5∆::ADE2 
“ 
C699-32 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste7∆::ADE2 
“ 
C699-33 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
fus3∆::ADE2 
“ 
C699-47 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste11∆::ADE2 
“ 
C699-80 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste7∆3::ura3∆58 fus3∆::ADE2 
“ 
C699-81 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste11∆::ADE2 ste7∆3::ura3∆58  
“ 
C699-82 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste5∆::ADE2 ste7∆3::ura3∆58  
“ 
C699-87 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste5∆:: ura3∆58 ste7∆3::ura3∆58 fus3∆::ADE2 
“ 
C699-89 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG 
ste7∆4::HisG 
“ 
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      Table 2.1 continued 
C699-90 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste5∆::ura3∆58 ste7∆3::ura3∆58 fus3∆::ADE2 kss1∆::kanMX6 
“ 
C699-91 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1∆::HIS3MX6  ura3-1 bar1∆::HisG FUS1-
LacZ::LEU2 ste5∆::ura3∆58 ste7∆3::ura3∆58 fus3∆::ADE2 kss1∆::kanMX6 
“ 
C699-92 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1∆::HIS3MX6 ura3-1 bar1∆::HisG FUS1-
LacZ::LEU2 ste5∆::ura3∆58 ste11∆6::ura3∆58 ste7∆3::ura3∆58 fus3∆::ADE2 kss1∆::kanMX6 
“ 
C699-93 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste11∆6::ura3∆58 fus3∆::ADE2 
“ 
C699-106 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1∆::HIS3MX6 ura3-1 bar1∆::HisG 
 ste7∆4::HisG 
“ 
C699-108 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste11∆6::ura3∆58 ste7∆3::ura3∆58 fus3∆::ADE2 
“ 
C699-112 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste7∆4::HisG 
“ 
C699-114 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste7∆::ADE2 kss1∆::kanMX6 “ 
C699-115 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste11∆::ADE2 ste7∆3::ura3∆58  kss1∆::kanMX6 “ 
C699-116 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste5∆::ADE2 ste7∆3::ura3∆58  kss1∆::kanMX6 “ 
C699-140 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1-1 ura3-1 bar1∆::HisG FUS1-LacZ::LEU2 
ste7∆3::ura3∆58 fus3∆::ADE2  kss1∆::kanMX6 “ 
C699-145 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1∆::HIS3MX6 ura3-1 bar1∆::HisG 
 ste7∆4::HisG fus3∆6::LEU2 “ 
C699-146 MATa ade2-1 can1-100 his3-11,15 leu2-3,112 trp1∆::HIS3MX6 ura3-1 bar1∆::HisG 
 ste7∆4::HisG kss1∆::kanMX6 “ 
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     Table 2.1 continued 
bK2149 MATa HLMa HMRa can1-100 leu2-3,112 trp1-1 ura3 ho::lacZ bar1::HISG ade2-1 met his3 
 
(67) 
bK2313 MATa HLMa HMRa can1-100 leu2-3,112 trp1-1 ura3 ho::lacZ bar1::HISG ade2-1 met his3 
fus3∆::LEU2 kss1::URA3 
(67) 
KZ8-1D MATα cyc1-1 CYC7 his4-38 ura1-1 K. Zaret and 
F. Sherman 
KZ8-5C MATa cyc1-1 CYC7 his4-38 ura1-1 K. Zaret and 
F. Sherman 
cMLY218a MATa  leu2  ura3 ste7∆::kanMX6 M. Lorenz 
and J. 
Heitman 
cMLY218α MATα  leu2  ura3-52 ste7∆::kanMX6 M. Lorenz 
and J. 
Heitman 
cSM-001 MATa  leu2  ura3 ste7∆::kanMX6 fus3∆-6::LEU2 
 
This work 
cSM-002 MATα  leu2  ura3-52 ste7∆::kanMX6 fus3∆-6::LEU2 
 
“ 
YHD1001 MATa ura3-52 lys2-801am ade2-1oc trp1∆63 his3-∆200 leu2-∆1 ste7::ADE2 ubp3::kanMX6  (26) 
 
 
aIsogenic to W303-1A 
bIsogenic to K1107 
cDerived from the Σ1278 background 
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     Table 2.2 Plasmids     
Plasmid  Allele Vector base (reference) Source or Reference 
    
pNC318 PCYC1-STE7M pNC160  [TRP1 CEN3 ARS1] (147) (187) 
pNC318-R220 PCYC1-STE7M-R220 “ (187) 
pNC318-N349 PCYC1-STE7M-N349 “ This work 
pNC571 PCYC1-STE7M-AA-S4T3 “ “ 
pNC586 PCYC1-STE7M-ST-A7 “ “ 
pNC589 PCYC1-STE7M-EE- S4T3 “ “ 
pNC597 PCYC1-STE7M-EE-A7 “ “ 
pNC892 PCYC1-STE7M-ST-E7 “ “ 
pNC893 PCYC1-STE7M-EE-E7 “ “ 
pNC894 PCYC1-STE7M-AA-A7 “ “ 
pNC895 PCYC1-STE7M-AA-E7 “ “ 
    
pNC752 STE7M “ “ 
    
pNC766 STE7M pRS316 [URA3 CEN6 ARS4] (166) This work 
pNC767 STE7M-AA- S4T3 “ “ 
pNC768 STE7M-EE- S4T3 “ “ 
pNC769 STE7M-ST-A7 “ “ 
pNC770 STE7M-EE-A7 “ “ 
pNC771 STE7M-N349 “ “ 
pNC781 STE7M-AA-A7 “ “ 
pNC790 STE7M-AA-E7 “ “ 
pNC791 STE7M-EE-E7 “ “ 
pNC793 STE7M-ST-E7 “ “ 
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     Table 2.2 continued 
Plasmid  Allele Vector base (reference) Source or Reference 
    
pNC809 PGAL-STE7M-EE-E7 pNC160 [TRP1 CEN3 ARS1] (147) “ 
pNC896 PGAL-STE7M-AA-A7 “ “ 
pNC897 PGAL-STE7M-EE-A7 “ “ 
pNC898 PGAL-STE7M-AA-E7 “ “ 
pNC906 PGAL-STE7M “ “ 
    
pEG-KT PGAL-GST pEMBLyex2 [LEU2-d URA3 2 µm] (4) (124) 
pNC901 PGAL-GST-FUS3 “ This work 
pNC903 PGAL-GST-KSS1 “ “ 
pRD-GST-STE111-717 PGAL-GST-STE11 pRS316 [URA3 CEN6 ARS4] (166) (128) 
pYBS293 PGAL-GST-STE5 YEpLac181[LEU2 URA3 2 µm] (74) (27) 
    
pNC977 PTPI1-KSS1M-TADH1 pRS313 [HIS3 CEN6 ARS4] (166) This work 
pNC979 PTPI1-FUS3M-TADH1 pRS316 [URA3 CEN6 ARS4] (166) This work 
    
pNC756 FUS1-LacZ Modified pLG∆178 [LEU2 2 µm] (77) This work 
pNC343     Ty-LacZ pLG∆178 [URA3 2 µm] (77) (12) 
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  Table 2.3 Ste7 promoted reporter gene expression in strains with deletions of MAPK activation module components. 
 β-galactosidase activity (mOD min-1 mg-1) 
  Column A B C D E F 
  Plasmid pNC318 pNC318 pNC597 pNC589 pNC893 pNC160 
   Ste7 Variant Ste7 Ste7 Ste7-EE-A7 Ste7-EE Ste7-EE-E7 None 
  Induction + - - - - - 
Row Strain Relevant Genotype Ty-LacZ Ty-LacZ Ty-LacZ Ty-LacZ Ty-LacZ Ty-LacZ 
1 C699-106 ste7∆ ---  400 +  20 8100 +  70 3500 + 100 5400 + 500  20 +  2 
2 C699-145 ste7∆ fus3∆ --- 3000 + 300 2400 +  70 4700 + 500 7100 + 300  20 + 10 
3 C699-146 ste7∆ kss1∆ ---   50 +  10   20 +  10   20 +  10   10 +  10  10 + 10 
   FUS1-LacZ FUS1-LacZ FUS1-LacZ FUS1-LacZ FUS1-LacZ FUS1-LacZ 
4 C699-32 ste7∆  2900 + 400   40 +   4   80 +  10    3 +   3    6 +   3   1 +  1 
5 C699-82 ste7∆ ste5∆ ---   10 +   3   50 +   5    8 +   6    6 +   3   1 +  1 
6 C699-81 ste7∆ ste11∆ ---    1 +   1  400 +  40    1 +   2    4 +   1   1 +  1 
7 C699-80 ste7∆ fus3∆  1000 + 100   50 +   7  200 +  20   20 +   4   30 +   3   9 +  3 
8 C699-127 ste7∆ ste11∆ste5∆ ---    5 +   3  350 +  10    8 +   3    9 +   3   2 +  2 
9 C699-87 ste7∆ ste5∆ fus3∆ ---   10 +   2 4700 + 300   10 +   4    20 +   2   6 +  3 
10 C699-108  ste7∆ ste11∆ fus3∆ ---   10 +   2  400 + 100    9 +   3    6 +   1   7 +  2 
11 C699-114 ste7∆ kss1∆  1600 + 400   50 +   5    6 +    1    4 +   1    8 +   2   6 +  1 
12 C699-116 ste7∆ ste5∆ kss1∆ ---    4 +   1    6 +    2    8 +   3    8 +   2   9 +  3 
13 C699-115 ste7∆ ste11∆ kss1∆ ---    4 +   2    8 +    1    7 +   1    3 +   1   6 +  1 
8
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                  Table 2.4.  Summary of activities promoted by constitutive Ste7 variants 
 
  Ste7-EE-A7 Ste7-EE-E7 
Phospho-Kss1 accumulation + + 
Phopsho-Fus3 accumulation - - 
Ste5 binding + - 
Kss1 binding  + + 
Fus3 binding - + 
Ty-LacZ reporter expression 
(Filamentation-specific) 
+ + 
FUS1-LacZ reporter expression 
(Mating-specific) 
STE5 FUS3 background 
 
- 
 
- 
FUS1-LacZ reporter expression 
(Mating-specific) 
ste5∆ fus3∆ background 
 
+ 
 
- 
 84
Figure 2.1:  Signal transduction pathways with common components mediate two life-
cycle transitions in haploid S. cerevisiae.  See text for explanation. 
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Figure 2.2:  Location of phosphorylation sites in Ste7 and SDS page mobility of variant 
proteins with phosphorylation site substitution mutations. 
(A) Residues phosphorylated in the activation loop of the catalytic domain (C) and 
feedback sites phosphorylated by Fus3/Kss1 in the regulatory domains (R).  (B and C)  
Western blots show mobility of Ste7 species that are characteristic of 
hyperphosphorylated (HP-Ste7) or hypophosphorylated (Ste7) forms after SDS-PAGE 
fractionation of protein extracts from uninduced (-) or induced (+) cultures as indicated.  
Residues at the activation loop (Loop) and feedback (FB) sites denote the different Ste7 
variants. Ste7M variants were expressed from the CYC1 promoter on plasmids in strain 
C699-89 (ste7∆) or C699-106 (ste7∆) using the following plasmids: pNC318 (Ste7M), 
pNC586 (Ste7M-A7), pNC892 (Ste7M-E7), pNC589 (Ste7M-EE), pNC597 (Ste7M-EE-
A7), pNC893 (Ste7M-EE-E7), pNC571 (Ste7M-AA), pNC894 (Ste7M-AA-A7),  pNC895 
(Ste7M-AA-E7).  
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Figure 2.3:  In vitro kinase activity of Ste7 phosphorylation site substitution derivatives.   
Upper panels show the PhosphorImage of 32P incorporation into Fus3R42 and lower 
panels show immune blots detecting immune precipitated Ste7 after SDS-PAGE 
fractionation of proteins from immune complex kinase assay reactions.  Cultures for 
these analyses were either untreated (-) or treated with pheromone (+), as indicated. 
Activities for each sample are calculated as [ 32P-Fus3 signal] / [IP-Ste7 signal].  The 
numbers below the immune blot report the activity for each reaction as a percentage of 
that obtained for the sample with pheromone induced Ste7 (ST-S4T3). (A) Samples in 
lanes 1-6 are from strain K2149 (FUS3KSS1) and in lanes 7-9 from strain K2313 (fus3∆ 
kss1∆) expressing catalytically inactive Ste7M-R220 (R220, pNC318-R220), wild-type 
Ste7M (Wt, pNC318), or Ste7M that cannot be feedback phosphorylated (A7, pNC586).  
(B) Samples in lanes 1-3, 6 and 7 are from strain K2149 (FUS3 KSS1) and lanes 4, 5, 8, 
and 9 from strain K2313 (fus3∆ kss1∆) expressing Ste7M (Wt, pNC318), constitutively 
active Ste7M (EE, pNC589) or constitutively active Ste7M that cannot be feedback 
phosphorylated (EE-A7, pNC597).  
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Figure 2.4:  Ubiquitin modification of Ste7 phosphorylation site variants.  
Western blots showing mobility of Ste7 species that are characteristic of the ubiquitinated 
(Ubi-Ste7), hyperphosphorylated (HP-Ste7) and hypophosphorylated (Ste7) forms.  (A) 
Ste7 proteins were expressed from the STE7 promoter in strain YHD1001 (ste7∆ ubp3∆) 
using plasmids pNC766 (Ste7M), pNC768 (Ste7M-EE), pNC770 (Ste7M-EE-A7), 
pNC791 (Ste7M-EE-E7), pNC781 (Ste7M-AA-A7) or pNC790 (Ste7M-AA-E7).  The 
same strain with vector (pRS316) was used as a negative reference. (B) Ste7 proteins 
were expressed from the CYC1 promoter in strain C699-32 (ste7∆) or strain C699-81 
(ste7∆ ste11∆) carrying pYES-UBP3C469S using plasmids pNC318 (Ste7M) or pNC597 
(Ste7M-EE-A7).  The same strain with vector (pNC160) was used as a negative reference.  
Relative Ubi-Ste7 is the signal intensity of the Ubi-Ste7 divided that for HP-Ste7 or Ste7. 
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Figure 2.5:  Mating and pheromone response assays comparing the in vivo function of 
Ste7 phosphorylation site substitution derivatives.  (A) Semi-quantitative mating assays.  
Photographs show diploid colonies selected for growth on minimal medium after an 
overnight incubation of mating mixtures at 30oC. Tester strain KZ8-1D (MATα, 1 x 106 
cells) was mixed with the indicated number of cells from strain C699-89 (MATa bar1∆ 
ste7∆) with a plasmid expressing the specified Ste7 variant from the STE7 promoter.  
(B) Pheromone induced reporter gene expression.  The bar graph shows the average β-
galactosidase activity for expression of the mating specific FUS1-LacZ reporter gene 
(pNC756) in two different strains carrying the specified Ste7M variant expressed from 
the STE7 promoter.  Averages are from four independent cultures of each variant in 
strain C699-89 (bar1∆ ste7∆) before (   ) and after (   ) 2 hr induction with 50 nM α-
factor and from four independent cultures of each variant in strain MLY218a (MATa 
ste7∆) before (   ) and after (   ) 2 1/2 hr  induction with 3 µM α-factor.  Error bars show 
the average deviation in measurements.  
 (C) Pheromone induced G1-arrest and mating differentiation.  The bar graph shows the 
average G1 arrest index (left axis) and the mating differentiation index (right axis) for 
samples from the same cultures used to measure reporter gene expression in (B).  The 
G1-arrest index [C699-89,  (    ); MLY218a, (    )] is the percentage of unbudded cells in 
each culture after pheromone induction minus the percentage of unbudded cells in the 
starting vegetative  culture. The differentiation index [C699-89, (    ); MLY218a, (   )] is 
the percentage of cells that formed mating projections.  Error bars show the average 
deviation in measurements.  Ste7 variants are expressed from the STE7 promoter using 
the following plasmids:  pNC766 (Ste7M), pNC769 (Ste7M-A7), pNC793 (Ste7M-E7), 
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pNC768 (Ste7M-EE), pNC770 (Ste7M-EE-A7), pNC791 (Ste7M-EE-E7), pNC767 
(Ste7M-AA), pNC771 (Ste7M-N349). 
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Figure 2.6:  Invasion assays comparing the in vivo function of Ste7 phosphorylation site 
substitution derivatives.  (A) Micrographs show invasive colonies from a section of 
growth chambers inoculated with strain MLY218a (ste7∆) carrying plasmids for 
expression of the Ste7 variants as specified in Fig. 4.  (B) Bar graph shows the average 
and average deviation of the invasive colony mean area from three independent 
experiments.  Measurements were made on 25 or more individual colonies in a given 
chamber after 46 to 48 hr of growth at 30oC.  Because few invasive colonies form with 
the strains expressing the catalytically inactive Ste7M-N349 and Ste7M-AA variants, the 
values are an average from measurement of only 9 and 11 total colonies, respectively. 
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Figure 2.7:  Comparison of Fus3 and Kss1 phosphorylation induced by pheromone or 
constitutive Ste7.  (A - C) The upper panel shows the total amount of Fus3M and Kss1M 
by detection with anti-myc antibodies.  The lower panel shows the fraction of dual 
phosphorylated Fus3M and Kss1M by detection with anti-Erk (pT-E-pY) antibodies.  The 
signals corresponding to Kss1M (K) and Fus3M (F) are indicated to the right of the blots.  
(A) Protein extracts (33 µg) were from strain C699-140 (STE5 ste7∆ fus3∆ 
kss1∆) expressing wild-type (Wt) Ste7 (pNC318), Ste7-EE-A7 (pNC587) or Ste7-EE-E7 
(pNC893) with Kss1M (pNC977), Fus3M (pNC979) or both, as indicated.  Lanes 1 and 2 
show extracts from the Wt-Ste7 strain before (-) and after (+) 15 min pheromone (α-fr, 
50 nM) induction.  (This time was empirically shown to result in optimal induction of 
Fus3 and Kss1 phosphorylation.)  Lane 9 shows an extract from the Ste7-EE-E7 strain 
with vectors (pRS313 and pRS316) as a negative reference.  (B and C) Lanes 1 and 2 
show extracts (66 µg) from strain C699-140 (STE5 ste7∆ fus3∆ kss1∆) expressing Wt-
Ste7 with Kss1M and Fus3M before (-) and after (+) induction with pheromone as 
specified in (A). Lanes 3-4 (B) or 3-5 (C) show extracts (33 µg) from strain C699-90 
(ste5∆ ste7∆ fus3∆ kss1∆) expressing Ste7-EE-A7 or Ste7-EE-E7 with Kss1M, Fus3M or 
both as specified.  Lane 6 (C) shows an extract from strain C699-90 expressing Ste7-EE-
A7 with vectors (pRS313 and pRS316) as a negative reference.  (D) Bar graph comparing 
the relative fold-induction phospho-Kss1 (    ) and phospho-Fus3 (   ) in strains as defined 
in (A-C).  Values are the average fold-induction determined from three experiments. Fold 
induction is the fraction of phospho-MAPK [anti-myc signal divided by anti-pT-E-pY 
signal] for each sample relative to that from the uninduced reference. The lines with bars 
show the average deviation in measurements.   
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Figure 2.8:  Co-purification assays comparing the in vivo binding of Ste7 phosphorylation 
site substitution derivatives to other components of the MAPK activation module.   (A-E)  
Representative western blots show the amount of indicated Ste7 variant and GST-fusion 
protein in the starting extracts (Input) and in the glutathione agarose immobilized fraction 
(Eluant).  Proteins were fractionated by SDS-PAGE.  Monoclonal anti-myc 9E10 
antibodies were used for detection of myc-epitope tagged Ste7 (Ste7M) derivatives and 
monoclonal anti-GST antibodies for detection GST or the indicated GST-fusion protein.  
Bar graphs show the average relative binding and average deviation for the specified 
Ste7M variant and GST-fusion protein.  Relative binding is the ratio of the anti-myc 
signal (Ste7) to the anti-GST signal (fusion protein) in the eluant fraction.  (A) Strain 
C699-93 (ste11∆ fus3∆) was used to co-express each Ste7M variant with GST-STE5 
(pYBS298).  Strain C699-92 (ste7∆ ste5∆ ste11∆ fus3∆ kss1∆) was used to co-express 
each Ste7M variant with the following:  (B) GST-STE11 (pRD-GST-Ste111-717), (C) GST-
FUS3 (pNC901), (D) GST-KSS1 (pNC903) or (E) GST (pEG-KT).  Indicated Ste7M 
variant proteins were expressed using the following plasmids: pNC896 (Ste7M-AA-A7), 
pNC897 (Ste7M-EE-A7), pNC898 (Ste7M-AA-E7), pNC809 (Ste7M-EE-E7).  
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Figure 2.9:  Invasion assays comparing wild-type and constitutive Ste7 variants in FUS3 
and fus3∆ genetic backgrounds.  (A) Micrographs show invasive colonies from a section 
of the invasion chambers inoculated with strain MLY218α (FUS3 ste7∆) or SM002 
(fus3∆ ste7∆) carrying plasmids for expression of wild-type (Wt) Ste7 (pNC766), Ste7-
EE-A7 (pNC770), Ste7-EE-E7 (pNC791) or catalytically inactive Ste7-N349 (pNC771) as 
indicated.  (B) Bar graph shows the average and average deviation of the invasive colony 
mean area from three independent experiments.  Measurements were made after 46 to 48 
hr of growth at 30oC.  The number of colonies measured in each experiment depended on 
the Ste7 variant and FUS3 background.  Chambers of the FUS3 strain with functional 
Ste7 variants contained 29-127 invasive colonies; those of the corresponding fus3∆ strain 
contained 53-230 invasive colonies.  Chambers of the negative reference (Ste7-N349) 
strains contained 7 to 27 invasive colonies.    
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Figure 2.10:   Model for regulation of the mating pathway MAPK cascade.  
See text for explanation. 
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CHAPTER 3 
A PATHWAY SPECIFIC SUBSTITUTION VARIANT OF STE7 REVEALS A 
NOVEL ROLE FOR MPK1 IN INVASIVE GROWTH TRANSCRIPTION 
 
Abstract 
 In this study we employ a pathway specific Ste7 kinase to examine the role that 
the scaffold protein, Ste5, plays in maintaining signal specificity.  Using a reverse two-
hybrid strategy we obtained a single amino acid substitution variant of Ste7 that is 
severely impaired for its ability to bind to Ste5.  As expected this mutant variant of Ste7 
does not activate Fus3 and does not function in the mating differentiation signaling 
pathway.  This variant, however, functions better than wild-type in promoting 
transcription of the invasive growth reporter gene Ty1-lacZ.  An unexpected finding was 
that the MAPK involved in cell wall synthesis, Mpk1, was phosphorylated at higher 
levels in strains expressing the Ste7 substitution mutant variant than in strains expressing 
wild-type Ste7.  Using deletion mutants we show this increased transcriptional output is 
dependent on Mpk1.  This analysis uncovers a novel role for this MAPK functioning in 
the transcriptional program associated with invasive growth in haploid cells. 
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Introduction 
Under the appropriate environmental stimulus haploid yeast are capable of two 
distinct developmental programs.  One developmental program causes haploid yeast to 
differentiate into a mating competent form, the other program causes a switch from 
vegetative to invasive growth.  At the heart of each program is a mitogen-activated 
protein kinase (MAPK) signaling cascade.  Both developmental programs share the same 
enzymes in their MAPK cascades.  Because of this fact studying these developmental 
programs offers insights into how signaling specificity is maintained in biological 
systems.  
 The consequence of mating in yeast is the fusion of two haploid yeast cells of 
opposite mating types into a diploid cell.  The mating process is initiated when 
pheromone secreted from yeast of one mating type binds to the G-protein coupled 
receptor of the opposite mating type.  This binding event triggers the activation of a 
MAPK module that is comprised of the p21 (Cdc42)-associated kinase Ste20, the 
MAPKKK-Ste11, MAPKK-Ste7, and two MAPKs, Fus3 and Kss1 (19).  The MAPK 
module involved in mating differentiation is organized by the scaffold protein Ste5 which 
binds to Ste11, Ste7 and Fus3 (11, 56).  Kss1 does not bind directly to Ste5 but is 
associated with the module through its association with Ste7 (8).  Upon stimulation with 
mating pheromone both MAPKs, Fus3 and Kss1, are induced to an equivalent extent with 
respect to their kinase activities.  Fus3 possesses specificity for critical substrates that 
Kss1 does not.  An example of one such substrate is the Cdk inhibitor Far1 which is 
necessary for the G1 arrest that is prerequisite for mating differentiation (8, 26, 62). 
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 The transcriptional response of mating differentiation is promoted equivalently by 
Fus3 and Kss1 through their activation of the transcription factor Ste12 (8, 58, 71).  The 
MAPK dependent activation of Ste12 is accomplished through phosphorylation-
dependent inactivation of two transcriptional inhibitors, Rst1 (Dig1) and Rst2 (Dig2) 
(66).  After removal of the transcriptional inhibitors Ste12 can function at mating-specific 
genes (MSG) as a homo-multimer at promoters with repeated pheromone response 
elements (PREs) or alternatively in conjunction with Mcm1 at promoters with P-box 
elements in proximity to a PRE (20, 23).   
 Both haploid and diploid cells can make a transition from vegetative growth to 
filamentous growth.  In diploid cells this differentiation is called pseudohyphal growth. 
Growth on solid medium containing a sufficient carbon source but limited nitrogen 
triggers the developmental change in yeast (55).  A related transition occurs in haploid 
cells on rich medium when glucose becomes limited or upon exposure to high alcohol 
(17, 31, 41, 55).  The characteristic features of both transitions are that cells become 
highly elongated, have a unipolar budding pattern, and maintain a cell wall attachment at 
the mother-daughter neck.  This phenotype results in chains of cells emanating from the 
periphery of colonies (55).   
 The transition to filamentous growth is controlled by a network of several 
signaling pathways.  One branch of the network involves the glucose-sensing G-protein-
coupled receptor, Gpr1.  This receptor functions with the Gα-Gpa2 along with Ras2 to 
regulate cyclic AMP (cAMP) production and therefore protein kinase A activity (31, 55).  
The MAPK-mediated branch is responsive to the transmembrane proteins Sho1 and 
Msb2 (16, 18).  The MAPK activation module involved in this transition is identical to 
 115
the mating differentiation MAPK module with the notable exceptions that Fus3 and Ste5 
are dispensable for signaling (5, 44).   
 In a similar fashion to the mating differentiation signaling MAPK module 
activation of Kss1 leads to activation of the Ste12 (5, 13, 14, 44, 66).  Unlike the mating 
differentiation pathway, Ste12 functions in cooperation with Tec1 at promoter elements 
that contain a Tec1 consensus binding sequence in proximity to PRE binding elements 
for Ste12 or TCS elements alone without PREs (7, 13, 38, 44).  Also, Rst1 (Dig1) is the 
major inhibitor for Tec1-Ste12 complexes involved in transcription of filamentous 
growth genes (13).   
 The transcriptional output for both the mating differentiation and invasive growth 
response is dependent on the same transcription factor (Ste12) and the same inhibitor 
proteins (Rst1/Rst2).  Recent work has highlighted some subtle differences in both 
pathways that contribute to signaling specificity.  One mechanism for specificity is the 
Fus3 phosphorylation-dependent degradation of Tec1 in response to mating pheromone 
stimulation (3, 12).  A second mechanism of specificity involves the dependence of Fus3 
activation by Ste7 on the scaffold protein Ste5 (2, 29, 47).  Initial work done in insect 
cells demonstrated an intrinsic difference in how Fus3 was activated by Ste7 and that the 
difference was dependent on the presence of Ste5 (8).  This work was further supported 
by Andersson et al. who showed that by using a constitutively active Ste11 that Ste5 was 
necessary for Fus3 activation but not for Kss1 activation (2).  Work done in our lab 
demonstrated this same fact using constitutively active Ste7.  A further implication of our 
analysis was that it is not sufficient to simply bind to Ste5 but proper orientation of Ste7 
and Fus3 on the scaffold Ste5 may be necessary for Fus3 activation.  Our lab also 
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demonstrated that persistent activation of Kss1 by constitutively active Ste7 supported 
transcription of a filamentous growth reporter gene but not a mating specific reporter 
gene (47).  These results were supported by the work done by Flatauer et al. who also 
examined the role of the scaffold protein Ste5 in its contribution to cross-talk in cell 
signaling.  They concluded that when Ste5 is in the inactive state Ste11 signals through 
Ste7 and Kss1 as observed in the invasive growth signaling pathway.  Upon stimulation 
with mating pheromone Ste5 becomes active and allows for signaling through Fus3 but 
does not insulate Ste7 and Ste11 but rather promotes cross-talk with other pathways by 
increasing the amount of active Ste11 available in the cell through the adaptor function of 
Ste5 (29).   
Materials and Methods 
Yeast genetic procedures and strains.  Yeast strains are listed in table 3.1.  
Strain YCJ4 was a gift from Jeremy Thorner (UC Berkeley) (36).  This strain contains the 
GAL4-UAS promoter driving expression of the URA3 gene and the lexA DNA sequence 
upstream of the lacZ gene.  Strain C699-32 contains the ste7 gene disrupted with the 
ADE2 genetic marker and the FUS1-lacZ promoter integrated at the LEU2 locus using 
one step gene replacement.    Transformations were carried out using the Li-Acetate 
method.  Standard yeast media was prepared as described elsewhere (47). 
 Oligonucleotides.  All oligonucleotides are listed in Table 3.2.  To amplify the 
GFPuv coding sequence oligonucleotides 366/367 were used.  The resulting PCR product 
created GFPuv coding sequence in frame with the 3’ coding sequence of STE7 and added 
an eight amino acid linker between the last amino acid in STE7 and the first amino acid 
of GFPuv.  To amplify STE7 oligonucleotides 241/369 were used.  The resulting PCR 
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product added a BamHI site at the 5’ end of STE7 and placed the coding sequence in 
frame with the GAL4 DNA binding domain in the 2-hybrid vector pMA424.  The 3’ end 
of this STE7 contained no stop codon but now had the sites XhoI, AflII, MscI, and BamHI 
added on the 3’ end.  The oligonucleotides 347/318 were used to amplify the GAL4-
STE7-GFPuv template for constructing the reverse two-hybrid library.  Oligonucleotide 
347 annealed to a sequence in the GAL4 DNA binding domain.  Oligonucleotide 318 
annealed to a sequence in the pMA424 vector downstream of the BamHI cloning site.  
The resulting PCR product contained the entire coding sequence of STE7 and GFPuv as 
well as DNA sequences with homology to the pMA424 vector at both the 5’ and 3’ ends..  
These areas of homology are necessary for homologous recombination to occur when 
linearized vector (pMA424) was co-transformed with the PCR generated point mutant 
library for STE7. 
 Plasmids construction.  Plasmids used in this study are listed in table 3.3.  The 
reverse two-hybrid “bait” library of STE7 mutants was constructed by PCR amplifying 
STE7 using oligonucleotides 241 and 369.  These oligonucleotides added a BamHI site on 
the 5’ end of STE7 and removed the stop codon at the 3’ end while adding XhoI, AflII, 
MscI, and BamHI to the 3’ end.  This STE7 containing PCR product was cloned into 
pUC119.  The GFPuv coding sequence (Clontech) was then PCR amplified from the 
pGFPuv plasmid using oligonucleotides 366 and 367 (Clontech) and the resulting PCR 
product was cloned into the TOPO-TA vector.  This PCR reaction added AflII sites to the 
5’ and 3’ ends of GFPuv coding sequence.  The resulting plasmid consisting of the 
TOPO-TA vector containing the GFPuv coding sequence was then subjected to a round 
of site directed muatgenesis using the “tail to tail” method of PCR using oligonucleotides  
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374 and 375 in order to remove the BamHI site in GFPuv (40).  The resulting GFPuv 
coding sequence was then purified from this plasmid by digesting it with AflII and 
isolating the 725 bp fragment.  This fragment was then ligated into the AflII site in 
pUC119 containing the STE7 coding sequence with the 3’ XhoI, AflII, MscI sites 
described previously.  The resulting plasmid contained pUC119 with the STE7 coding 
sequence with GFPuv fused in frame with STE7.  The 2 kb fragment from this plasmid 
containing the STE7-GFPuv fusion was then cloned into pMA424 as a BamHI fragment.  
The resulting plasmid contained the STE7-GFPuv coding sequence in frame with the 
GAL4 DNA binding domain (BD) and was named pNC913.  The resulting plasmid 
(pNC913) served as a template for the PCR reactions to create a library of point mutants.  
Gal4-AD Ste5 was a gift from George Sprague.  To express the mutant versions of STE7 
in yeast under its endogenous promoter and without the Gal4 DNA binding domain and 
GFPuv fusions mutant alleles of STE7 isolated from the reverse two-hybrid screen were 
subcloned from the pMA424 vector into the pUC119 vector as a BamHI fragment in an 
orientation such that the ATG start codon of STE7 was distal to the SphI site in pUC119.  
A Myc tag was then added to the STE7 alleles using annealed oligonucleotidess 626/627 
as a XhoI/SphI fragment.  This step replaced the C-terminal GFPuv with a Myc tag.  
Subsequently a 1.3 kb MscI-SphI fragment was then cloned from the pUC119 vector into 
the pNC752 vector cut with MscI-SphI to replace the wild-type STE7 coding sequence 
with the chosen STE7 substitution allele.  The same 1.3 kb XhoI/SphI fragment was also 
cloned into pNC809 cut with MscI and SphI to replace the STE7-E9 sequence with the 
chosen mutant sequence.  The resulting plasmid allowed for a galactose inducible version 
of the Myc tagged mutant STE7 allele.  The GAL-GST-STE5 plasmid is a gift from 
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Elaine Elion (Harvard).  All clones of PCR products were sequenced after to ensure no 
secondary mutations occurred during the PCR reaction. 
 Polymerase Chain Reaction (PCR) and generation of STE7 point mutation 
library.  All reactions were done using Pfu turbo as the thermostable polymerase unless 
specified.  The conditions used were as suggested by the vendor unless otherwise 
specified.  The oligonucleotides used in each reaction are as listed previously and in table 
3.2.  The GFPuv coding sequence was amplified using Taq polymerase and oligos 
366/367 to allow for cloning into the TOPO-TA vector.  The STE7 library of point 
mutations was generated by using PCR utilizing oligonucleotides 347 and 318, Taq 
polymerase, and a total reduced nucleotide pool (dNTPs) at a concentration of 0.2 mM 
(0.05mM each dNTP).  This concentration yielded an average of one mutation per gene.  
 Library Screening.  YCJ4 was transformed with the Gal4AD-STE5 plasmid first 
and a single clone was then grown in –Leu media and co-transformed with linearized 
pMA424 and mutant library PCR product in a 3:1 ratio of PCR product to vector.  The 
resulting transformants were selected on –His-Leu media to ensure both plasmids were 
present.  Transformants were then replica plated to 5-FOA media and colonies that grew 
were picked and re-streaked onto 5-FOA media a second time.  Each clone was then 
grown and tested for the presence of GFP.  Clones that were 5-FOA resistant and 
expressing GFP were then grown in –His media and the plasmid containing the STE7 
mutant was recovered and re-transformed into YCJ4 containing Gal4AD-STE5 to verify 
authentic 5-FOA resistance.  STE7 mutant plasmids were then sequenced to identify 
where any point mutations occurred. 
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 Threaded Model Programs.  The threaded model of the catalytic core of Ste7 
was modeled based upon the crystal structure of the catalytic core of TGF-β with PDB 
accession 1B6C.  The templates used for building the homology model for the catalytic 
core of Ste7 were accessed using the Phyre program (www.sbg.bio.ic.ac.uk/phyre).  The 
homology model was built using the Modeler module of the Insight II molecular 
modeling system from Accelrys Inc. (www.accelrys.com) and evaluated for sequence-
structure compatibility using the Verify-3D function of the Profiles-3D module.   
 FUS1-lacZ reporter assays.  FUS1-lacZ assays were performed as described in 
Chapter 2 of this dissertation.  In brief, yeast strains carrying an integrated genomic 
reporter construct FUS1-lacZ and plasmids that allowed for expression of wild-type Ste7 
or a substitution variant were grown to a cell density of 1x107 in –Ura media.  Cells were 
then induced with α-factor at a 50nM concentration for 2 hours.  Cells were then counted 
for percent budding and for mating projection formation.  Cells were then harvested and 
frozen in liquid nitrogen.  The frozen aliquots of cells were then lysed and assayed for the 
expression of β-galactosidase based on the standard assay using ONPG as a substrate.  
 GST Co-Purifiactions.  GST Co-purifications were performed as described in 
chapter 2 of this dissertation. 
 Immune blotting conditions for analysis of dual-phosphorylated Fus3, Kss1, 
and Mpk1.  Strain C699-89 (ste7∆) was transformed with a low copy plasmid with the 
endogenous promoter for expression of wild-type Ste7, Ste7L194S, or vector alone.  
Cultures of each strain were grown in selective media (-Trp) to a cell density of 1 x 107 
cells/mL.  A 10 mL sample was taken before addition of α-factor as an uninduced 
reference.  The remaining portion of each culture was treated with 50nM α-factor with 
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cells harvested at 10, 15, 20 and 120 minutes after addition of pheromone.  Cells were 
harvested as described by Mattison C.P et al. by centrifugation and suspended in 60µL of 
L1 buffer (90 mM NaHEPES pH7.5, 2% SDS, 1mM dithiothreitol) and boiled for three 
minutes.  After boiling 60µL of ice cold L2 buffer (50mM NaHEPES pH7.5, 5mM 
EDTA, 150mM NaCl, 1% Triton X-100, 1mM PMSF, 1mM Na-o-Vanadate, 40mM β-
Glycerophosphate, and 20µg/mL each of Leupeptin, Pepstatin A, Antipain, Aprotinin, 
and Chymostatin) was added to each sample (49).  Samples were then placed at -20°C.  
60µL of each sample were then mixed with 60µL of 2X SDS-PAGE loading buffer and 
boiled for 5 minutes.   
Samples were then fractionated by SDS-PAGE on duplicate 8% gels and 
transferred to Immun-Blot PVDF (Bio-Rad) membranes.  Each filter was then incubated 
in 6M Guanidine-HCl buffer as described in Mimnaugh E.G. et al. (6M Guanidine-HCl, 
20mM Tris pH 7.5, 5mM dithiothreitol, 10mM PMSF) for 30 minutes at room 
temperature prior to blocking (50).  One filter was used for detection of the total amount 
of Kss1, Fus3, and Mpk1 with anti-Kss1, anti-Fus3, or anti-Mpk1 goat polyclonal 
antibodies (Santa Cruz) at 0.2µg/mL with rabbit anti-goat horseradish peroxidase-
conjugated IgG (Santa Cruz) at 0.04µg/mL.  The duplicate filter was used to detect the 
fraction of dual-phosphorylated Kss1, Fus3, and Mpk1 by using anti-phospho p44/p42 
MAPK rabbit polyclonal antibodies (Cell Signaling Technologies) at a 1:500 dilution 
with goat anti-rabbit horseradish peroxidase-conjugated IgG (Cell signaling 
Technologies) at a 1:2000 dilution.  
Secondary antibodies were detected using Enhanced Chemiluminescence (ECL) 
by mixing equal volumes of Reagent 1 (0.1M Tris pH 9.0, 0.13 mM P-coumaric acid, 0.7 
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mg/mL luminol) and Reagent 2 (0.1M Tris pH 9.0 and 2% stablilized peroxide (Pierce)) 
and incubating at room temperature for one minute.  Filters were then exposed to X-ray 
film.  
 Immune blotting conditions for analysis of Tec1 degredation.  Strain C699-
154 (ste7∆ TEC1-13XMyc) was transformed with a low copy plasmid with the 
endogenous promoter for expression of wild-type Ste7, Ste7L194S, or vector alone.  
Cultures of each strain were grown in selective media (-Trp) to a cell density of 1 X 107 
cell/mL.  A 10mL sample was taken before the addition of α-factor as an uninduced 
reference.  The remaining culture was treated as above except samples were taken at 30, 
60, and 120 minute intervals.   
 Samples were fractionated by SDS-PAGE on 10% gels and transferred to Immun-
Blot PVDF (Bio-Rad) membranes.  Filters were cut horizontally and one portion was 
used for detection of Tec1 with anti-c-myc goat polyclonal antibodies (Santa Cruz) at 
0.2µg/mL with rabbit anti-goat horseradish peroxidase-conjugated IgG (Santa Cruz) at 
0.04µg/mL.  The other portion of the filter was used to detect Tub1 as a loading control 
with rat anti-tubulin antibody at 0.17µg/mL with goat anti-rat horseradish peroxidase-
conjugated IgG (Santa Cruz) at 0.04µg/mL. 
 Secondary antibodies were detected as above. 
Results 
Reverse two-hybrid screen for mutations that disrupt Ste7 binding to Ste5.  
The reverse two-hybrid screen identifies mutations that disrupt the interaction between 
two proteins (68).  The screen requires a “bait” protein fused to the Gal4 DNA binding 
domain (BD) and a previously identified binding partner fused to the Gal4 transcriptional 
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activation domain (AD).  The recipient strain for co-expression of the two fusion proteins 
carries a URA3 allele under control of the GAL4-UAS (Upstream Activating Sequence) 
that serves as a reporter for their interaction.  Any mutation in the “BD-bait” protein that 
abolishes its interaction with its AD-binding partner will result in a failure to tether the 
activation domain at the UAS and thereby disable URA3 expression.   The resulting Ura3 
deficiency allows cells to be counter selected on media containing the compound 5-
flouroorotic acid (5-FOA) (1). 
 Our study uses BD-Ste7 as the “bait” protein along with its known binding 
partner AD-Ste5 (Figure 3.2).  We incorporated two features into the BD-Ste7 bait to 
improve the efficiency of this screen.  Previous studies showed that alanine substitutions 
at the seven residues that are feedback phosphorylated by the MAPKs Kss1 and Fus3 
resulted in a Ste7 derivative (Ste7A7) with improved binding to Ste5 (47).  We took 
advantage of this stronger binding variant for our screen and fused the Gal4-BD domain 
to the N-terminus of Ste7A7.   We then fused GFP to the C-terminus of BD-Ste7A7 to 
provide a rapid secondary screen for identifying the subset of 5-FOA positive clones that 
express a full length bait protein (22).   BD-Ste7A7 and BD-Ste7A7-GFP show the same 
two-hybrid interaction with AD-Ste5 (data not shown).  Therefore, the GFP fusion does 
not interfere with Ste7 binding to Ste5. 
 To generate a library of point mutations in BD-Ste7A7-GFP we utilized a PCR 
based strategy that exploits the inherent infidelity of the thermostable Taq polymerase 
(10).  The resulting library was transformed into a yeast strain that already carried a 
plasmid expressing AD-Ste5 (see methods).  Approximately 500 colonies were isolated 
on 5-FOA containing medium.  Among these colonies, 22 were also positive for 
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expression of GFP.  Only 11 of the 22 plasmids recovered from this set resulted in 5-
FOA insensitive and uracil auxotrophs when transformed into a naїve strain. 
 The Ste7A7 intervals of the 11 plasmids recovered in this screen were then 
sequenced to identify the mutations responsible for disrupting the two-hybrid interaction.  
The majority of the alleles have multiple substitution mutations with only three having a 
single substitution (Table 3.4).   Strikingly, each of the alleles had at least one 
substitution that mapped to one of three clusters (Figure 3.3A).  This pattern suggests that 
the substitutions in these three locations are important for the observed disruption of the 
two hybrid interaction with Ste5.  Two of these regions (I and II) are within the catalytic 
core of Ste7 and the third (III) is in the C-terminal regulatory domain.  Three substitution 
mutations were located in the N-terminal regulatory domain of Ste7.  These N-terminal 
substitutions were recovered only in conjunction with substitutions located in at least one 
of the three clusters.  Furthermore, the N-terminal regulatory domain was previously 
shown to be neither necessary nor sufficient for Ste7 binding to Ste5 (11).  For these 
reasons, substitutions in the N-terminal regulatory domain were considered less likely 
than those in the clustered regions to identify residues that may be critical for the Ste7-
Ste5 interaction. 
 Threaded model of Ste7.   Identification of the specific residues that are critical 
for the Ste7-Ste5 binding interaction requires assessment of derivatives with a single 
amino acid substitution.  Our premise for prioritizing the above substitutions for this 
assessment is that surface exposed residues with non conservative substitutions are those 
most likely to disrupt the Ste7-Ste5 binding interaction without affecting structural 
integrity.  To aid in the selection of such residues from those represented by the 
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substitutions in the Ste7 two-hybrid derivatives, we constructed a threaded model of the 
catalytic core of Ste7 (21, 28, 34).  
 CDK2 (PDB ID 1GZ8), AKT-2 (PDB ID 1O6L), PAK-1 (PDB ID 1F3M), IGF-1 
(PDB ID 1P4O), and TGF-β (PDB ID 1B6C) were tested as templates for the threading 
model of the 271 amino acid catalytic core of Ste7 (33, 35, 39, 52, 70).   These five 
kinases were chosen as templates because they have known crystal structures and show 
high sequence similarity to Ste7.   The TGF-β structure proved to be the best template 
upon which to build the catalytic core structure of Ste7 (Figure 3.3B).  The self 
compatibility score using the TGF-β template was 95.8 with 55.4 being the lowest and 
123.2 being the highest respective scores for a peptide sequence of 271 amino acids (42).  
The 3D self compatibility score calculated with this template was 0.6.  A 3D self-
compatibility score of 1.0 is typical of a crystal structure while a score of 0.0 denotes an 
incorrect structure.   Threaded models are reported in the literature with 3D self 
compatibility scores as low as 0.2 and scores above 0.5 are generally accepted as reliable 
(51, 63).   
 The mutations identified in the reverse two-hybrid screen that mapped to cluster I 
are located in β-sheet 1 of the Ste7 ATP binding lobe (amino acids 191-199) (Figure 
3.3A and B, green).  The mutations that mapped to cluster II are located in or adjacent to 
the E-helix of the Ste7 substrate binding lobe (amino acids 304-320) (Figure 3.3A and B, 
yellow).  Notably, both of these secondary structural elements are located on the face of 
Ste7 that is opposite to the activation loop residues Ser359 and Thr363 which are also 
highlighted in the model (Figure 3.3B, magenta). 
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 The residues with substitutions that are most likely to be surface exposed are L194 
and K196 from cluster I and W301 from cluster II (Figure 3.3B, red).  Ste7A7 derivatives 
(lacking the Gal4BD and GFP fusions) with single L194S, K196E, and W301R substitutions 
were then generated by site directed mutagenesis for further analysis.   To contrast with 
the presumed surface exposed group, we similarly generated Ste7A7 derivatives with 
single L315P and V337G substitutions that target residues the model predicts to be buried 
(Figure 3.3B, blue).  L315 is a part of the E-helix that is critical for maintaining the 
architecture of the conserved kinase catalytic core.  V337 appears to form contacts with 
this helix and therefore may also be important for structural integrity.  Although cluster 
III substitutions are located in the C-terminal domain, which is outside of the model, a 
Ste7A7 derivative with a single C482R substitution was also generated as a representative 
of substitutions in this domain.    
 Ste7 function in the mating and filamentation transcriptional responses.  We 
applied an empirical criterion to distinguish those residues that may be critical for Ste7 
binding to Ste5 from those that merely impair Ste7 structural integrity.  It is based on the 
circumstance that Ste7 is essential for both mating and filamentation transcription 
programs whereas Ste5 is critical only for the mating program (44, 45, 59, 60).  Thus, 
substitution mutations at residues that specifically disrupt binding to Ste5 are predicted to 
abolish pheromone induced expression of the mating specific FUS1-lacZ reporter gene 
without affecting expression of the filamentation specific Ty1-lacZ reporter gene.  Those 
substitutions that adversely affect the structural integrity of Ste7 are expected to abolish 
both while those that are neutral will affect neither. 
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 All of the single substitution derivatives except for Ste7A7-K196E showed severely 
impaired pheromone induced β-galactosidase activity expressed from the FUS1-lacZ 
reporter gene (Table 3.5).  We infer that the single substitution at residue K196 is 
insufficient to disrupt the Ste7-Ste5 binding interaction but that each of the other single 
substitutions perturbs Ste7 function.   Of this latter group, only the Ste7A7-L194S 
derivative maintains the ability to promote Ty1-lacZ reporter gene expression and this 
activity is 4-fold higher than that for wild-type Ste7 (Table 3.5). Therefore, the L194S 
derivative meets the criterion for a substitution that potentially affects the binding of Ste7 
to Ste5 without disrupting the Ste7 structure.  We also examined whether the L194S 
substitution would confer the same functional characteristics to a version of Ste7 without 
alanine substitutions at the feedback phosphorylation sites (Ste7-L194S).  The Ste7-L194S 
derivative also failed to activate transcription of the FUS1-lacZ reporter gene in response 
to mating pheromone but activated the Ty1-lacZ reporter gene better than wild type Ste7 
(Table 3.5).  It has previously been shown that Ste7 with alanine substitutions at two 
residues in the activation loop  (Ste7-S359A,T363A) is inactive (32, 53, 72).  We therefore 
made a derivative with these substitutions (Ste7-L194S, S359A, T363A) to test whether 
activity of the putative Ste5 binding defective mutant is required for Ty1-lacZ reporter 
gene expression. β-galactosidase activity in the strains expressing either Ste7-
S359A,T363A or Ste7-L194S, S359A,T363A remained at the background amount seen for the 
control strain without any Ste7 (Table 3.5).  This outcome reinforces our inference that 
the L194S substitution by itself is not sufficient to abolish Ste7 activity.  
 The Ste7 derivatives that support neither FUS1-lacZ nor Ty1-lacZ reporter gene 
expression result from substitutions at residues in region II, whether these were predicted 
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surface exposed (W301R) or buried (L315P, and V337G),  and the region III (C482R).  We 
attribute this failure to function in either response as an indicator that these different 
substitutions compromise the Ste7 structure and catalytic activity.  We cannot rule out the 
alternative possibility that any one of these residues might otherwise be critical for Ste7 
function in promoting both transcriptional programs. 
 GST co-purification assay for assessment of Ste7 binding to Ste5.  To confirm 
that the L194S substitution is sufficient to weaken the binding interaction between Ste7 
and Ste5, we employed a GST-Ste5 co-purification assay.   The GST-Ste5 fusion protein 
for this analysis was expressed from the GAL1,10 promoter in the same strain with 
different myc tagged Ste7 substitution derivatives, also under control of the GAL1,10 
promoter.  The amount Ste7A7-L194S  that co-purifies with GST-Ste5 was compared to 
that for two other derivatives, Ste7A9 and Ste7E9, which serve as references for strong 
and weak binding, respectively (47).  An interaction between GST-Ste5 and Ste7A7-L194S 
was still detectable using overexpressed proteins.  However, the interaction was severely 
compromised compared to that seen with the Ste7A9 reference and is somewhat weaker 
than the interaction with Ste7E9 reference (Figure 3.4A).  The results of this analysis 
support the conclusion that the L194S substitution mutation identifies a key residue 
required for strong binding of Ste7 to Ste5.   
 Exclusion of Ste7 from the scaffold complex enhances filamentation gene 
expression under uninduced and pheromone induced conditions.   Inactive Fus3 and 
Kss1 each have negative regulatory effects on filamentation gene expression.  However, 
the active MAPKs have opposing regulatory roles.  Whereas active Kss1 has been 
attributed a positive regulatory role, active Fus3 inhibits the program by promoting Tec1 
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degradation (3, 4, 6, 12, 15, 25, 46, 62, 66).  Evidence from several studies revealed that 
Ste7 requires the scaffold-Ste5 for activation of Fus3 but not Kss1 (2, 8, 29, 47).  
Therefore, exclusion of Ste7 from the scaffold complex should impair Fus3 but not Kss1 
activation.  This condition should enhance Ty1-lacZ reporter gene expression because 
negative contributions from active Fus3 are diminished.   To examine whether this simple 
model is sufficient to explain enhanced reporter gene activity in strains with Ste7-L194S 
compared with Ste7, we examined Ty1-lacZ reporter gene expression in strains having a 
deletion of STE5 (ste5∆), FUS3 (fus3∆) or KSS1 (kss1∆).  Previous work has shown that 
filamentation-specific transcription is increased modestly (~2-fold) in response to mating 
pheromone (7, 59, 62).  Therefore, we also compared each of these strains under 
uninduced and pheromone induced conditions to determine how pheromone treatment 
influences the balance of regulation from active vs. inactive MAPKs.  
 Pheromone treatment causes the same (2-fold) induction of reporter activity in the 
strain expressing Ste7-L194S as in the strain with wild-type Ste7 (Table 3.6).  This result 
suggests that effect of pheromone is independent of recruiting Ste7 to the scaffold 
complex.  Consistent with this interpretation, the strain with Ste7-L194S showed little 
difference in reporter activity whether Ste5 is present or absent. However, the absence of 
Ste5 resulted in a two-fold increase in activity for the strain with wild-type Ste7 (Table 
3.6).   It is also notable that the absence of Ste5 did not eliminate a further induction upon 
pheromone treatment (Table 3.6).  The latter result confirms that the effects of 
pheromone are independent of Ste5.  Although reporter gene expression in both the Ste7 
and Ste7-L194S strains occurs in the absence of Ste5, neither version of Ste7 bypasses the 
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requirement for Ste11.  Specifically, no reporter activity above the background amount is 
seen with either Ste7 or Ste7-L194S in the ste11∆ strain (Table 3.6).   
A key prediction of the above model is that Ste7-L194S will not activate Fus3 and 
therefore should have a complete dependence on Kss1 for promoting reporter gene 
expression.  As expected, Ste7-L194S fails to promote reporter activity above the 
background amount in the kss1∆ strain (Table 3.6).  By contrast, wild-type Ste7 supports 
reporter activity when Fus3 is the sole MAPK, albeit to lesser amounts than when Kss1 is 
also present (Table 3.6).  Notably, there is a 7-fold increase in reporter activity in the 
kss1∆ strain under pheromone induced compared with uninduced conditions.  This 
stimulation correlates with conditions leading to Fus3 activation and therefore suggests 
that active Fus3 also has a positive role in promoting filamentation-specific gene 
expression.    
When Kss1 is present in the absence of (fus3∆) there is an increase in both 
uninduced and pheromone induced reporter activity whether the response is mediated by 
Ste7 or Ste7-L194S (Table 3.6).   This enhancement is consistent with the elimination of 
negative regulation imposed by either active or inactive Fus3.  However, if regulation 
through Fus3 were the only operative mechanism, reporter activities in the fus3∆ strain 
should be the same for Ste7 and Ste7-L194S.   Instead, reporter activity with Ste7-L194S 
remains 2-fold higher than that for Ste7.  The same trend is also apparent in the 
comparisons made in the ste5∆ strain where we postulate neither Ste7 nor Ste7-L194S are 
expected to activate Fus3.  This pattern suggests that Ste7-L194S has positive effects on 
the transcriptional activation through mechanisms that are independent of Fus3. 
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The simplest hypothesis to explain these results is that Ste7-L194S might be a 
more potent activator of Kss1 than wild-type Ste7.  However, this appears not to be the 
case.  (See below.)   A less obvious hypothesis is that Ste7-L194S some how involves 
Hog1 or Mpk1 in the promotion of filamentation specific reporter gene expression.  To 
test this latter possibility, we compared reporter gene expression in the wild-type strain to 
that in strains with a deletion of Hog1 (hog1∆) or Mpk1 (mpk1∆).   It has previously been 
observed Hog1 has a negative effect on diploid pseudohyphal development (44, 54).  
Consistent with this negative role, Ty1-LacZ reporter gene expression is stimulated in 
hog1∆ haploid cells compared with HOG1 cells expressing either Ste7 or Ste7-L194S 
(Table 3.6).   Ty1-LacZ expression is also enhanced in the mpk1∆ strain compared with 
the MPK1 strains expressing wild-type Ste7.  However, the mpk1∆ Ste7-L194S strain 
shows a 10-fold decrease in Ty1-LacZ expression compared with the MPK1 Ste7-L194S 
strain (Table 3.6).  This surprising finding reveals a novel role for Mpk1 in promoting 
filamentation-specific gene expression that is dependent on Ste7-L194S.  
 Comparison of Ste7 and Ste7-L194S for differential phopshorylation of Fus3, 
Kss1, and, Mpk1.  To assess the phosphorylation status of Fus3, Kss1, and Mpk1, we 
used immune blot detection methods to compare differences in strains expressing either 
Ste7 or Ste7-L194S under uninduced and pheromone induced conditions.  These 
comparisons were made for the endogenous MAPKs in the same strain that was used for 
assessment of reporter gene activities (Table 3.6).  Extracts of the different cultures were 
fractionated on duplicate gels by SDS-PAGE, which resolves the three MAPKs, and 
transferred to nitrocellulose for immune blot analysis.  Anti-Fus3, Anti-Kss1, Anti-Mpk1 
antibodies were used on one filter to determine the total amount of each MAPK present 
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under the different conditions (Figure 3.5A, lower panel) (4, 62).  The duplicate filter was 
used to detect the amount each MAPK that is dually phosphorylated (pT-E-pY) by using 
anti-phospho Erk antibodies  (4, 62).  Extracts from two reference strains lacking either 
Fus3 and Kss1, or Mpk1 were used as negative controls.  
 All three MAPKs show a time-dependent increase in pheromone induced dual 
phosphorylation in the extracts prepared from the Ste7 strain (Fig. 3.5A, lanes 1-3 and 
Figure 3.5B).  As predicted for a version of Ste7 that is excluded from the Ste5 scaffold, 
no phosphorylated Fus3 is detected in the extracts prepared from the Ste7-L194S strain 
(Figure 3.5A, lanes 4-6).   By contrast, Kss1 is detectably phopshorylated in the Ste7-
L194S strain (Figure 3.5A lanes 4-6).  Because the amount of dual-phosphorylated Kss1 is 
the same or less than seen in the Ste7 strain, the results refute the hypothesis that Ste7-
L194S is a more potent activator of Kss1 than wild-type Ste7.  However, there are elevated 
amounts of dually phosphorylated Mpk1 in the Ste7-L194S strain compared with the Ste7 
strain under uninduced and induced conditions (Figure 3.5A and B).  Our interpretation 
of this finding is that active Mpk1 contributes to the stimulation of Ste7-L194S mediated 
Ty1-LacZ reporter gene expression.  
 Tec1 is more stable in pheromone treated cells expressing Ste7-L194S 
compared wild-type Ste7.  Filamentation specific-genes containing FREs (Filamentation 
Response Elements) in their promoters are dependent on Ste12-Tec1 heteromers for their 
transcription.  Active Fus3 inhibits the Ste12-Tec1 program because Fus3, but not Kss1, 
phosphorylates Tec1 and thereby targets the protein for ubiquitin dependent degradation.  
Because Ste7-L194S does not activate Fus3, we hypothesized that Tec1 should be more 
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stable in strains with Ste7-L194S compared with wild-type Ste7.   Such stabilization could 
also make a positive contribution to filamentation specific reporter gene expression.   
We examined the amounts of myc tagged Tec1 (Tec1M) in Ste7-L194S and Ste7 
strains that were either untreated or treated with pheromone (Figure 3.6A).   Samples 
were taken from parallel cultures at the indicated times for preparation of extracts that 
were fractionated by SDS-PAGE and transferred to nitrocellulose for detection of Tec1M 
using anti-myc antibodies.  Tub1 was detected on the same blots by using anti-tubulin to 
provide an internal reference (Figure 3.6A).   The amount of Tec1 is reported as the ratio 
of the Tec1 signal to that of Tub1 and is relative to the ratio of theses signals for the  
sample at  t=0 for the corresponding culture (Figure 3.6B).  The amount of Tec1 
remained stable over the two hour time course in both the Ste7 and Ste7-L194S cultures 
without pheromone treatment.  The expected time-dependent decline in the relative 
amount of Tec1M is seen in samples from the Ste7 culture treated with pheromone but 
not in the samples from the Ste7-L194S culture (Figure 3.6A, B).   To directly compare the 
amounts Tec1 in the Ste7-L194S and Ste7 strains, we analyzed samples from uninduced 
cultures of the two strains on the same blot (Figure 3.6C).  The amount of Tec1 is 
comparable in both strain backgrounds, showing that differences in Tec1 abundance do 
not contribute to differences in Ty1-lacZ reporter activities under uninduced conditions.   
However, the increased stability of Tec1 during pheromone induction with Ste7-L194S 
compared with Ste7 could contribute to the increase in Ty1-lacZ reporter activity 
promoted by pheromone treatment in Ste7-L194S strains. 
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Discussion 
Reverse two-hybrid screen uncovers a pathway specific Ste7 varaint.  Ste7 is 
the MAPKK in both the mating differentiation and filamentous growth pathways.  In the 
former pathway Ste7 activates two MAPKs, Fus3 and Kss1, and in the latter pathway it 
activates only Kss1.  The mechanism by which Ste7 activates the two appears to be 
different.  Ste7 activates Fus3 only when both are present on the scaffold, Ste5, whereas 
Ste7 activates Kss1 without Ste5 (2, 8, 29, 47).  Ste5 and Fus3 are essential for mating 
differentiation but not filamentous growth.  A mutant version of Ste7 that does not bind 
to Ste5 should activate only Kss1.  Because persistent activation of Kss1 promotes 
filamentous growth but blocks mating differentiation (47), we hypothesized the resulting 
mutant would be pathway specific. To identify such a mutant, we first identified a set of 
Ste7 variants containing single amino acid substitutions that no longer allowed for 
binding to Ste5 using a reverse two-hybrid strategy.  From this set, a pathway specific 
Ste7 variant was identified using the empirical criterion that the variant is unable to 
activate a mating specific reporter gene (FUS1-lacZ) but maintains the ability to activate 
a filamentation specific reporter gene (Ty1-lacZ).  One variant, Ste7-L194S, met this 
criterion and also showed reduced binding to Ste5 in a GST co-purification assay.  Using 
the threaded model we determined that the location of the substation mutation was in β-
sheet two of the small lobe of the catalytic core of Ste7.  This β-sheet is surface exposed 
on a face opposite that of the activation loop.  We infer that this face of small lobe of Ste7 
is part of the surface that binds to Ste5. 
 Effect of mating pheromone in yeast expressing Ste7-L194S versus wild-type 
Ste7.  Ste5 is required to bring the MAPK cascade enzymes to the site of activated G-
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proteins at the pheromone receptor upon stimulation by mating pheromone and this co-
localization is needed to activate the cascade (27, 37, 69).  We predicted that because the 
Ste7-L194S has a reduced association with Ste5 that this variant would eliminate any 
pheromone induced activation of downstream effectors.  Instead we observed a two-fold 
pheromone induced induction of Kss1 dual phosphorylation in strains expressing Ste7-
L194S.  Although this induction of Kss1 dual phosphorylation is five-fold less than for 
wild-type Ste7, both support the same two-fold induction of Ty1-lacZ reporter gene 
expression in response to pheromone stimualtion.   In addition, deleting Ste5 did not 
abolish the pheromone induced transcription in strains expressing either wild-type Ste7 or 
Ste7-L194S.  These findings suggest that Ste11 is still able to activate Ste7 off the scaffold 
and that pheromone induced transcription of Ty1-lacZ is independent of Ste5.  These 
conclusions are in agreement with the findings of Flatauer et al. that activation of Ste11 
in response to mating pheromone activates Ste7 even when it is not bound to Ste5 (29).       
 Previous work has shown that Spa2, Far1, Bni1, and Pea2 all form a 
“polariosome” in response to mating pheromone (48, 61, 65, 67).  It has also been shown 
that Bni1 interacts with Cdc42 at the cell membrane when Cdc42 is interacting with free 
Gβγ  (48).  Bni1 also interacts with Spa2, a protein known to interact with Ste7 and Ste11 
among other proteins (30, 64).  Thus the addition of mating pheromone may recruit both 
Ste5 and the “polariosome”, including Spa2 associated with Ste11 and Ste7, to the same 
location at the plasma membrane.  It is possible that by disfavoring the association 
between Ste7-L194S and Ste5 we are now favoring an association with Spa2.  This new 
protein complex containing Spa2, Ste11, and Ste7 located at the plasma membrane at 
activated pheromone receptors may facilitate Ste11 activation by Ste20.  Active Ste11 in 
 136
turn activates Ste7, and leads to Kss1 mediated activation of transcription of Ty1-lacZ 
reporter gene.      
  Fus3 inhibits invasive growth specific transcription by mechanisms that are 
independent of Tec1 degradation.  Activated Fus3 inhibits the filamentation growth 
pathway by phosphorylating Tec1, which leads to its ubiquitin dependent degradation (3, 
12).  The Ste7-L194S substitution variant does not activate Fus3 because this activation 
requires the formation of a ternary complex of Ste5, Ste7, and Fus3 (2, 29, 47).   If the 
only inhibitory mechanism by which activated Fus3 inhibits filamentation specific gene 
expression is through the degradation of Tec1, we would expect to observe similar levels 
of Ty1-lacZ reporter gene expression in yeast strains deleted for Fus3 and expressing 
either wild-type Ste7 or Ste7-L194S.  In contrast to the expectation, Ty1-lacZ reporter 
gene expression in strains lacking Fus3 was 2 and 3 fold higher for strains expressing 
Ste7-L194S compared with strains expressing wild-type Ste7 in the absence and presence 
of pheromone,  respectively.  This outcome suggests that there are additional inhibitory 
functions for Fus3 in the filamentous growth pathway that are independent of its 
activation.   
  Activation of Mpk1 in strains expressing Ste7-L194S substitution variant.  A 
simple hypothesis to explain the elevated expression of the Ty1-lacZ reporter gene in 
strains expressing Ste7-L194S as compared with wild-type Ste7 is that the mutant variant 
hyperphosphorylates Kss1.  However, Kss1 phosphorylation in strains expressing Ste7-
L194S is approximately 40 percent of the maximal amount that is seen in strains 
expressing wild-type Ste7.  The finding that there was no correlation between Kss1 
phosphorylation and Ty1-lacZ reporter gene expression suggested the alternate 
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hypothesis that another MAPK might be contributing to the transcriptional response.  
This hypothesis is supported by two observations.   First, strains expressing Ste7-L194S 
show an increase in dual phosphorylation of Mpk1 compared with that seen in strains 
with wild-type Ste7.  Second, deleting Mpk1 caused an almost ten-fold decrease in the 
basal levels of transcription of Ty1-lacZ in strains expressing Ste7-L194S.   
 Previous findings by Andersson et al. indicate that Mpk1 phosphorylation is 
dependent on Ste5 in strains expressing the constitutively active STE11-4 allele (2).  
Based on these results one would not expect the Ste7-L194S allele to support Mpk1 
phosphorylation because it does not associate with Ste5.  One notable difference between 
the two experiments is use of the STE11-4 allele.  The high activity associated with this 
STE11 allele may be hyperactivating negative feedback mechanisms that lead to 
inhibition of phosphorylation of Mpk1.  An alternate explanation to reconcile the 
differences between the two sets of data is that wild-type Ste7 may require Ste5 to 
localize it for its role in Mpk1 activation while the Ste7-L194S variant does not have this 
requirement.   
 Two models for the mechanism by which Ste7-L194S causes the elevated dual 
phosphorylation of Mpk1 relative to wild-type Ste7 are considered.  One model proposes 
that Ste7-L194S directly phosphorylates and activates Mpk1 (Figure 3.7B). According to 
this model the L194S substitution mutation in Ste7 enhances its association with the Sph1 
organized complex consisting of Ste11, Ste7, and Mpk1 (61), which facilitates Ste7-L194S 
activation and its subsequent phosphorylation and activation of Kss1 and Mpk1.  Sph1 is 
a protein homologous to Spa2 and is localized to areas of polarized growth in vegetative 
and pheromone induced cells (61).    A second model proposes that Ste7-L194S indirectly 
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activates Mpk1 as a consequence of responses that are dependent on Kss1 activation 
(Figure 3.7C).  In this model Kss1 may phosphorylate and activate targets upstream of 
the Mpk1 MAPK module or promote expression of Ste12 dependent proteins may lead to 
activation of upstream targets of the Mpk1 MAPK module.      
 To determine whether the direct or indirect Mpk1 activation mechanism applies, 
we will examine the dual phosphorylation status of Mpk1 in strains expressing Ste7-L194S 
and deleted for the MAPKKs Mkk1 and Mkk2 that normally function to phosphorylate 
Mpk1 in the cell wall integrity pathway.  If there Mpk1 phosphorylation is conserved in 
the STE7-L194S mkk1∆ mkk2∆ genetic background, we will examine the associations 
between wild-type Ste7 and Ste7-L194S and the MAPKs Kss1, Fus3, and Mpk1 by doing 
co-purification binding assays.  The finding that Ste7-L194S binds to Mpk1 would provide 
additional support for the direct phosphorylation model.   If Mpk1 phosphorylation is not 
observed in the STE7-L194S mkk1∆ mkk2∆ genetic background, we will examine indirect 
mechanisms through which Ste7-L194S and active Kss1 might promote its 
phosphorylation.  For example, we will test whether Spa1, Bni1 or Ste12 might be 
necessary to mediate Mpk1 phosphorylation promoted by Ste7-L194S.  We focus on these 
three proteins because they have been implicated previously as having roles in 
pheromone induced phosphorylation and activation of Mpk1 (9).   One or the other 
protein would be implicated in the Ste7-L194S promoted mechanism if Ste7-L194S 
expressing strains with single deletions of these components show diminished or 
abolished dual phosphorylation of Mpk1.  
   The Ste7-L194S substitution variant uncovered a novel role for Mpk1 in 
promoting expression of a filamentous-specific reporter gene.  It remains unclear if this 
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role is specific to strains expressing Ste7-L194S or if it is also utilized in strains expressing 
wild-type Ste7.  If it is specific to Ste7-L194S, we infer that this substitution mutation 
might provide some structural insights into how Ste7 specifically selects MAPK 
substrates.  This outcome would implicate the β-sheet two of the small lobe of the 
catalytic core in addition to the MAPK docking motif at the N-terminus as being 
important in determining which MAPKs Ste7 can bind and activate.  If instead the Ste7-
L194S mutant promotes activation of Mpk1 by indirect mechanisms dependent on Kss1, 
the findings reveal a feed-forward mechanism for coordinating activities of the 
filamentous growth MAPK cascade and the cell-wall integrity cascade that may be 
generally important (Figure 3.7A).  The rationale for coordination of these two activities 
is that one of the hallmarks of filamentation is hyperpolarized growth for cell elongation.  
Sustaining such growth requires extensive cell-wall remodeling activities that are 
dependent on Mpk1.  Such evidence would serve to highlight that MAPK signaling in 
yeast is not a simple one kinase per pathway mechanism but rather a network of kinases 
working at different threshold levels of activation to achieve signaling goals.  
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Table 3.1 S. cerevisiae strains 
Strain Genotype Source or 
Reference 
YCJ4 MATa can1-100 leu2-3, 112 trp1-901 ura3-52 gal80-538 gal4-
542 ade2::GAL4p-URA3 lys2::lexAop-lacZ 
(36) 
C699 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1 K. 
Nasmyth 
C699-5 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
bar1∆::HisG 
(24) 
C699-32 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
bar1∆::HisG FUS1-lacZ::LEU2 ste7∆::ADE2 
(47) 
C699-89 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
bar1∆::HisG ste7∆4::HisG 
(47) 
C699-145 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 
trp1∆::HIS3MX6 ura3-1 bar1∆::HisG ste7∆4::HisG 
fus3∆6::LEU2  
(47) 
C699-146 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 
trp1∆::HIS3MX6 ura3-1 bar1∆::HisG ste7∆4::HisG 
kss1∆::kanMX6 
(47) 
C699-164 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 
trp1∆::HIS3MX6 ura3-1 bar1∆::HisG ste7∆4::HisG 
ste5∆::ADE2 
This Work 
C699-165 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 
trp1∆::HIS3MX6 ura3-1 bar1∆::HisG ste7∆4::HisG 
ste11∆::ADE2 
This Work 
C699-154 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
bar1∆::HisG ste7∆4::HisG TEC1-13XMyc::HIS3MX6 
This Work 
C699-168 MATa ade2-1 can1-100 his3-11,15 leu2-3, 112 trp1-1 ura3-1 
bar1∆::HisG ste7∆4::HisG mpk1∆::HIS3MX6 
This Work 
  
   Table 3.2 Oligonucleotides used   
Purpose Oligo 
No. 
Sequence 
Ste7 Mutagenesis    
L194 -> S194  807 5’ CTC CAG GAC TCT GTT CAG TCT GGG AAA ATT GGT 
   GCT GG 
K196->E196 808 5’ CTC CAG GAC TCT GTT CAG TTG GGG GAA ATT GGT 
   GCT GG 
Reverse primer for 807,  
808 
809 5’ TTG TAT ATA ATT ACC ATT TGA GGT AAC CGA C 
W301->R301 Fwd 810 5’ TTC AAC GAG CTC ACA ATA TCA AAA ATA CGC 
W301->R301 Rev 811 5’ TCT GGT TTT CTT ACT CGA AAC AGT CCC TC 
    
Ste7 Mutation Library   
Construction 
  
GE-19 241 5’ CCG GGA TCC TGG TCA TGT TTC AAC GAA AG 
ST7mipl 369 5’ TAC TAG GGA TCC TCA TGG CCA CTT AAG CTC GAG 
   ATG GGT TGA TCT  
GFP5Afl 366 5’ TAC TAG CTT AAG GCT GCT ATG AGT AAA GGA GAA GAA 
GFP3Afl 367 5’ TAC TAG CTT AAG TTA TTT GTA GAG CTC 
GFPn5BA 374 5’ AAT GAA GAT GGT TCC GTT CAA 
GFPn3BA 375 5’ GTT GTG GCG AAT TTT GAA GTT 
R2H5prim 347 5’ GCG ACA TCA TCA TCG GAA GAG 
seqoli 318 5’ TCA TAA GAA ATT CGC CCG GA 
   
Ste7 Sequencing 
Primers 
603F 
604R 
5’ ATT GCA GAA CCG GTT GAA AAC 
5’ ATT GGA CAA TCC CTG AAT CG 
ST7seq2  348 5’ GCG TAC AGT AAT AAT TTC GGA 
ST7seq3 349 5’ CTG TCC GTT TAT AAA AGG TTT 
1
4
1
 
  
Table 3.2 continued 
ST7seq4 350 5’ ATA GGT GTT GTA TTA AGA ATG 
   
PCR Targeting   
Tec1-Myc Round1 Fwd 801 5’ ATC CAA CCA ATC GCA TGG GAA CTT TTA TCG GAT 
   CCC CGG GTT AAT TAA 
Tec1-Myc Round1 Rev 802 5’ TCT TAC TAC GAA GAT ACG TAT GCG TAT TTA TGT 
   ACG AGA TGT ATG TAT G 
Tec1-Myc Round2 Fwd 803 5’ ACA TTC TCC ACA TCA AAG GAA CTT TAC GCC ATC 
   CAA CCA ATC GCA TGG G 
Tec1-Myc Round2 Rev 804 5’ TGT ACG AGA TGT ATG TAT GTA TGT AGA CAT GAA 
   TTC GAG CTC GTT TAA AC 
Deletion of MPK1   
Dmpk1F1 839 5’ ATT GAA GGG GTA TAA CAA TTC TGG GAG CGG ATC 
   CCC GGG TTA ATT AA 
Dmpk1R1 840 5’ TAC TTC CCC GGT TAC TTA TAG TTT TTT GTC GAA 
   TTC GAG CTC GTT TAA AC 
Dmpk1F2 841 5’ CTT ATT GAA GCT ATC AAA ATA GTA GAA ATA ATT 
   GAA GGG CGT GTA TAA CAA TTC TGG GAG 
Dmpk1R2 842 5’ GTC TGT AAG CTT ACA TCT ATG GTG ATT CTA TAC 
   TTC CCC GGT TAC TTA TAG TTT TTT GTC 
 
 
 
 
 
 
 
 
1
4
2
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      Table 3.3 Plasmids used 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Plasmid  Allele Vector Base  Source or  
reference 
Reverse two-hybrid   
pMA424 PADH-GAL4BD HIS3 2µm (43) 
pSL2287 PADH-GAL4AD-Ste5 LEU2 2µm (56) 
pNC913 PADH-GAL4BD-Ste7A7-GFP HIS3 2µm This work 
    
GST Co-Purification   
pYBS293 PGAL-GST-STE5 LEU2 URA3 2µm (11) 
pNC809 PGAL-STE7M-EE-E7 TRP1 CEN3 ARS1 (47) 
pNC896 PGAL-STE7M-AA-A7 TRP1 CEN3 ARS1 (47) 
pNC1109 PGAL-STE7L194SM-ST-A7 TRP1 CEN3 ARS1 This work 
    
Ty1/FUS1-lacZ Assays   
pNC160 Vector TRP1 CEN3 ARS1 (57) 
pNC752 STE7M TRP1 CEN3 ARS1 (47) 
pNC758 STE7M-A359,A363 TRP1 CEN3 ARS1 This work 
pNC1096 STE7A7-Q482R TRP1 CEN3 ARS1 This work 
pNC1097 STE7A7-L315P TRP1 CEN3 ARS1 This work 
pNC1100 STE7A7-V337G TRP1 CEN3 ARS1 This work 
pNC1105 STE7A7-W301R TRP1 CEN3 ARS1 This work 
pNC1108 STE7A7-L194S TRP1 CEN3 ARS1 This work 
pNC1110 STE7L194S TRP1 CEN3 ARS1 This work 
pNC1118 STE7A7-K196E TRP1 CEN3 ARS1 This work 
    
pNC343 Ty-lacZ URA3 2µm (7) 
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Table 3.4 STE7 alleles selected in a reverse two hybrid screen for Ste5 binding mutants. 
Allele Substitutions Cluster Representation 
BD-ste7A7-GFP-100 D22N, L188F, F302S I,  II, III 
BD-ste7A7-GFP-132 W301R, K384R III 
BD-ste7A7-GFP-157 L194S, Q261P II 
aBD-ste7A7-GFP-169 
BD-ste7A7-GFP-229 
C482R IV 
BD-ste7A7-GFP-179 R4Q, K196E, E272K I, II 
BD-ste7A7-GFP-187 F302L, I308M III 
BD-ste7A7-GFP-196 V337G, Y469G III, IV 
BD-ste7A7-GFP-208 N51D, L191S, K437E, R454G, D475G I, II and IV 
BD-ste7A7-GFP-268 L338P, K493R III, IV 
BD-ste7A7-GFP-303 L315P III 
aTwo independent isolates 
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    Table 3.5 Comparison of mating and filamentation specific reporter gene expression 
     in strains with different Ste7 substitution variants.  
 Ste7 Variant aFUS1-LacZ 
(mOD min-1 mg-1) 
bTy1-LacZ 
(mOD min-1 mg-1) 
Ste7 1445 + 226 118 + 11 
Ste7-S359A,T363A N/A 5 + 2 
Ste7A7 1521 + 109 269 + 19 
Ste7A7-L194S 1 + 1 303 + 81 
Ste7-L194S 3 + 2 490 + 24 
Ste7-L194S, S359A,T363A N/A 5 + 1 
Ste7A7-K196E 1229 + 97 922 + 108 
Ste7A7-W301R 2 + 1 26 + 3 
Ste7A7-L315P 3 + 2 18 + 2 
Ste7A7-V337G 2 + 1 12 + 2 
Ste7A7-C482R 103 + 6 67 + 7 
None 2 + 1 6 + 3 
a Pheromone induced (2 hr, 3 µM α-factor) 
b Uninduced 
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Table 3.6 Comparison of Ste7 and Ste7L194S for promotion of filamentation reporter gene 
expression in strains with deletions of different pathway components. 
 
Relevant Genotype Ste7 Ste7L194S Vector 
     aInduction                 - + - + - + 
ste7∆ 118 + 11 331 + 98 490 + 24  971 + 52 6 + 3 4 + 4 
ste7∆ ste5∆ 214 + 14 399+ 31 417 + 67  717 + 72 5 + 3 6 + 3 
ste7∆ ste11∆   6 + 3 N/A 12 + 4 N/A 9 + 3 N/A 
ste7∆ fus3∆ 475 + 62 671 + 32 931 + 65 1901 + 24 4 + 1 3 + 1 
ste7∆ kss1∆ 32 + 11 231 + 24 8 + 2    9 + 2 4 + 2 2 + 2 
ste7∆ kss1-
T183A,Y185F 
8 + 5 N/A 7 + 2 N/A 6 + 2 N/A 
ste7∆ hog1∆ 606 b N/A 883 b N/A 5 b N/A 
ste7∆ mpk1∆ 183 + 16 N/A 51 + 13 N/A 3 + 1 N/A 
 
a   -, Uninduced;   +, Pheromone induced (2 hr, 3 µM α-factor) 
b Average of two assays on same culture 
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Figure 3.1:  Signal transduction pathways for yeast mating pathway and filamentous 
growth pathway.  Note the shared components of the MAPK cascade.  Also see text for 
explanation. 
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Figure 3.2:  Rationale for reverse two-hybrid screen.  Random point mutations in bait 
protein (Ste7) disrupt binding to known binding partner (Ste5).  C-terminal tag of GFP on 
bait provides secondary screen to ensure full length bait proteins are being expressed. 
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Figure 3.3:  Location of mutations obtained from reverse two-hybrid screen and threaded 
model of Ste7.  (A)  Schematic drawing of Ste7 showing clustering pattern of mutations 
obtained in reverse two-hybrid screen.  Cluster I is highlighted in green and located in the 
β-sheet rich region of the catalytic core of Ste7 (see below).  Cluster II is highlighted in 
yellow and represents residues that are in proximity or located inside the E-helix of the 
catalytic core.  Cluster III is located in the unique C-terminal tail of Ste7.  Residues 
labeled in red (Cluster I and III representatives) or blue (Cluster II representatives) were 
tested as single point mutations in Ste7 for the ability to activate transcription of the Ty1-
lacZ invasive growth reporter gene.  (B)  Threaded model of Ste7 catalytic core.  The 
threaded model of Ste7’s catalytic core was built using TGF-β as a template.  Green 
residues correspond to green regions in schematic in (A).  Yellow residues represent E-
helix.  Red and Blue residues correspond to residues in (A).  Magenta residues represent 
the Ser and Thr of the activation loop of Ste7.   
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Figure 3.4:  Co-purification assay comparing the in vivo binding of the Ste7-L194S 
substitution variant with Ste7-A9 and Ste7-E9.  (A)  Representative blot shows the 
relative amount of GST-Ste5 and Ste7 in the starting extracts (input) and in the 
glutathione agarose immobilized fraction (eluant).  Proteins were fractionated by SDS-
PAGE.  Polyclonal anti-myc antibodies were used for detection of myc-epitope tagged 
Ste7 (Ste7M) derivatives and monoclonal anti-GST antibodies for detection of GST-Ste5.  
(B)  Bar graphs show the average relative binding and average deviation for the specified 
Ste7M variant and GST-fusion protein.  Relative binding is the ratio of the anti-myc 
signal (Ste7) to the anti-GST signal (fusion protein) in the eluant fraction.  Strain C699-
92 (ste7∆ ste5∆ ste11∆ fus3∆ kss1∆) was used to co-express each Ste7M variant with 
GST-Ste5. 
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Figure 3.5:  Relative amounts of phosphorylated Fus3, Kss1, and Mpk1 in yeast 
expressing wild-type or L194S substituted Ste7 after addition of α-factor.  (A) 
Representative blots showing phosphorylated Fus3, Kss1, and Mpk1.  Upper panel 
represents proteins detected by anti-pT-E-pY (anti p44/42) antibodies that react with 
dually phosphorylated Fus3, Kss1, and Mpk1.  Lower panels represent total protein of 
indicated MAPK (Fus3, Kss1 or Mpk1) as detected with antibodies for each specific 
MAPK.  (B)  Bar graph representing percent maximum MAPK phosphorylation.  The 
maximum phosphorylation was determined to be Fus3 (   ) after 120 minutes of exposure 
to 50nM α-factor.  The relative amounts of phosphorylated Kss1 (    ) and Mpk1 (   ) 
were compared to the maximum phosphorylation of Fus3.  (C)  Bar graph representing 
total amounts of each MAPK, Fus3 (   ), Kss1 (   ), and Mpk1 (   ), as compared to the 
basal amount of each MAPK in yeast expressing wild-type Ste7 without exposure to 
α−factor.   
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Figure 3.6:  Relative stability of Tec1 in yeast expressing wild-type Ste7 versus Ste7-
L194S at basal levels and after exposure to mating pheromone.  (A)  Representative blots 
showing the relative amount of Tec1 in yeast strains expressing wild-type Ste7 and Ste7-
L194S without mating pheromone (uninduced) and with mating pheromone (induced with 
50nM α-factor).  Tec1 was tagged with a 13x-myc tag and detected with polyclonal anti-
myc antibodies.  Tubulin was used as a loading control and detected with anti-tubulin 
antibodies.  (B)  Graph showing Tec1 degradation upon exposure to mating pheromone in 
yeast cells expressing only wild-type Ste7.  Tec1 levels in uninduced wild-type Ste7 are 
represented by an open triangle (?), uninduced Ste7-L194S are represented by an open 
circle (○), induced wild-type Ste7are represented by a closed circle (●), and induced 
Ste7-L194S are represented by a closed triangle (▲).  (C)  Duplicate blots of Tec1 in 
uninduced yeast expressing wild-type Ste7 and Ste7-L194S.  The relative amounts of Tec1 
to Tubulin are shown below each lane. 
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Figure 6.7:  Models of Mpk1 activation.  See text for explanation.  (A)  Wild-type Ste7.  
(B)  Direct mechanism of phosphorylation of Mpk1 by Ste7-L194S.  (C)  Indirect 
mechanism of phosphorylation of Mpk1 by Ste7-L194S.  
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CHAPTER 4 
GENERAL DISCUSSION 
 
 There are five MAPK signaling modules in yeast.  These MAPK modules are 
involved in signaling processes for mating, filamentous growth, high osmolarity 
adaptation, cell wall synthesis, and sporulation.  It is becoming clear that signaling via 
MAPK modules in yeast is not a linear event but rather due to a network of proteins.  It 
was originally proposed by Madhani et al. that there were distinct functions for the 
MAPKs Kss1 and Fus3 in mating and filamentous growth (11).  Here they propose that 
Fus3 is the MAPK used in the mating pathway while Kss1 is the MAPK used for 
filamentous growth (11).  This interpretation of their data was ultimately erroneous.  
Recent data from our lab and others has demonstrated that a linear signaling pathway is 
not a likely scenario.  It has been demonstrated by various labs that Kss1 and Fus3 are 
dually phosphorylated by Ste7 to an equal extent in response to mating pheromone (1, 3, 
12, 15).  Additionally the transcriptional output in response to mating pheromone is 
identical when activated by Kss1 or Fus3 (14).  One notable difference between the 
mechanism by which Ste7 phosphorylates Kss1 and Fus3 is that Fus3 phosphorylation 
requires the scaffold protein Ste5 while phosphorylation of Kss1 does not (1, 3, 9, 12).  
 Recent evidence has also demonstrated that MAPKs can play both positive and 
negative roles in various signaling pathways.  One such example is the MAPK Kss1.  
Unphosphorylated Kss1 inhibits filamentous growth while phosphorylated Kss1 
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promotes filamentous growth (7, 11).  In a similar fashion we demonstrated that 
unphosphorylated Fus3 was inhibitory for signaling in the mating pathway even when 
Kss1 was constitutively phosphorylated (12).  This inhibition was removed only when 
Fus3 was deleted along with the scaffold protein Ste5 (12).  These results suggest a 
synergistic effect both proteins have on inhibiting the transcriptional output of the mating 
pathway when Fus3 remains unphosphorylated.   
 Further evidence that MAPKs in yeast work in concert with each other is the 
inhibitory functions observed across pathways.  One such example is the MAPK Fus3 
inhibiting filamentous growth when activated by mating pheromone.  It was first 
observed that deleting Fus3 had a stimulatory effect on invasive growth (6, 11).  This 
effect was due to the fact that activated Fus3 leads to a phosphorylation and ubiquitin 
dependent degradation of the filamentous growth transcription factor Tec1 (2, 5).  It was 
also demonstrated that deleting the MAPK Hog1 also had a stimulatory effect on 
filamentous growth (10, 13).  In addition to stimulating filamentous growth, deleting 
Hog1 also allowed for cross-talk between the high osmolarity signaling pathway and the 
mating pathway.  The results of this cross-talk were transcriptional output and 
morphogenic changes typically observed in haploid yeast in response to mating 
pheromone now occurred in response to high osmolarity (13). 
 The MAPK involved in cell wall synthesis, Mpk1, is activated in response to 
stimuli that alter the shape of the plasma membrane (reviewed in (8)).  The polarized 
growth morphogenesis observed when haploid yeast encounter mating pheromone serves 
as a stimulus to activate Mpk1 (4, 8).  This activation of Mpk1 in response to mating 
pheromone is dependent on the transcriptional output and translation of genes regulated 
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by Ste12 (4).  Work done by Yashar et al. demonstrated that the MAPKK Ste7, which 
normally functions in the mating and filamentous growth MAPK signaling pathways, 
could compensate for deletions of the redundant MAPKKs Mkk1 and Mkk2, which 
activate Mpk1, when overproduced or in strains deleted for Ste5 and rescue yeast from 
lysis when heat shocked (16).  These results suggest that the scaffold protein Ste5 
promotes signaling specificity by tethering Ste7 and sequestering it from activating 
MAPKs other than Kss1 and Fus3 (16).  We found further evidence to support this Ste7 
cross-talk into the cell wall synthesis pathway with a substitution mutant derivative (Ste7-
L194S) that has reduced binding to Ste5.  When this mutant derivative of Ste7 is expressed 
in yeast cells we observe a 2-fold higher phosphorylation of Mpk1 in vegetatively 
growing cells when compared to cells expressing wild-type Ste7 (Chapter 3 of this 
thesis).  In conjunction with this increased phosphorylation of Mpk1 yeast expressing 
Ste7-L194S have higher levels of transcription of the filamentous growth reporter gene 
Ty1-lacZ when compared to cells expressing wild-type Ste7.   
 The work done by others and in this thesis supports the hypothesis that signaling 
in yeast via MAPK modules is not a linear event but rather involves a network of 
MAPKs.  One can speculate on how such a network could function in a differentiation 
pathway such as filamentous growth in yeast.  The stimulus for filamentous growth can 
lead to activation of Ste7 independent of Ste5.  This activation event would lead to Kss1 
activation without Fus3 activation.  Because polarized growth is a hallmark of 
filamentous growth Mpk1 is also activated by Mkk1 and/or Mkk2 but also perhaps by 
Ste7 to further reinforce signaling in this MAPK module.  Active Mpk1 in turn appears to 
be able to play a role in promoting transcription of filamentous growth specific genes.  
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Thus Ste7 can play a positive role in activating the MAPK involved in cell wall synthesis 
in response to polarized growth, Mpk1, while Mpk1 can in turn play a positive role in 
transcription of genes specific for filamentous growth. 
 The data presented in this thesis should impact the field of MAPK signaling in 
yeast by demonstrating the plasticity of MAPK networks functioning in signaling rather 
than rigid linear pathways.  Such plasticity could have arisen as an evolutionary survival 
advantage in that if one protein was unable to function in a given MAPK signaling 
pathway a protein from another pathway could function in its place.  As mentioned 
earlier Ste7 can function in the cell wall synthesis pathway when overexpressed or when 
Ste5 is deleted.  A possible suppression mechanism for mutations in components in the 
cell wall synthesis pathway could therefore be to increase levels of Ste7 or to decrease 
levels of Ste5.  MAPK signaling pathways in yeast should be observed for their global 
impact on the cell now and not just for their impact on one particular pathway.  
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